<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:dc="http://purl.org/dc/elements/1.1/">
  <channel>
    <title>Cancerevo: Evolution and cancer</title>
    <description>Nature Network blog posts from user 'David Basanta'</description>
    <link>http://network.nature.com/blogs/user/basanta</link>
    <language>en-us</language>
    <ttl>40</ttl>
    <item>
      <title>Drug for prostate cancer</title>
      <description>
        <![CDATA[<p><img src="http://www.maths.dundee.ac.uk/~basanta/me.jpg" alt="" /> Browsing the <a href="http://news.bbc.co.uk/1/hi/health/7502238.stm">BBC website</a> today I found news about an article at the <a href="http://jco.ascopubs.org/cgi/content/abstract/JCO.2007.15.9749v1">Journal of clinical oncology</a> that presents research with the potential to help men with end-stage prostate cancer.</p>


	<p>The article describes the Phase I clinical trial of a drug called Abiraterone acetate that so far seems to be quite efficacious (70-80% of patients reporting an improvement). The idea of the treatment is that prostate tumours rely on sex hormones (like testosterone) and that reducing or eliminating the production of some of these hormones will block tumour progression. As opposed to other treatments, the one tested by Dr. de Bono and his group and collaborators at London&#8217;s Institute of Cancer Research, blocks hormone production not only from healthy cells but also from the tumour cells themselves which might step in and produce what they need in order to keep growing.</p>


	<p>The news can be found in English [<a href="http://news.bbc.co.uk/1/hi/health/7502238.stm">BBC</a>] and in Spanish [<a href="http://www.elpais.com/articulo/sociedad/gran/paso/cancer/prostata/elpepusoc/20080722elpepusoc_2/Tes">El Pais</a>] although if you read the Spanish version you may get the idea that the entire work was carried out single-handed  by Dr. de Bono, the leader of the project.</p>]]>
      </description>
      <pubDate>Tue, 22 Jul 2008 22:05:54 -0000</pubDate>
      <link>http://network.nature.com/blogs/user/basanta/2008/07/22/drug-for-prostate-cancer</link>
      <guid>http://network.nature.com/blogs/user/basanta/2008/07/22/drug-for-prostate-cancer</guid>
      <dc:creator>David Basanta</dc:creator>
    </item>
    <item>
      <title>Cancer, wine and reporting</title>
      <description>
        <![CDATA[<p><img src="http://www.maths.dundee.ac.uk/~basanta/me.jpg" alt="" /> I haven&#8217;t posted much here lately as I have been touring Scotland (holidays) and on a quick trip to London (you call that business?). Yesterday was my first day back in Dundee and found <a href="http://www.guardian.co.uk/commentisfree/2008/jul/19/cancer.foodtech">this article</a> reading the paper. The Guardian has a weekly column that writes mostly about the way that science is reported in the mainstream media. This week&#8217;s seems to be about the dodgy connections that some journalists make between a scientific discovery and its implication to society.</p>


	<p><img src="http://www.repgallery.com/gallery/full/wine_lover_ii.jpg" alt="" /></p>


	<p>The point in case is a statement made by <a href="http://en.wikipedia.org/wiki/The_Daily_Telegraph">The Daily Telegraph</a> that <em>red wine could help to prevent cancer</em>. That comes from some research that shows that some component in grapes used to produce red wine, resveratrol, has an effect that, among other things, does reduce the chances of <span class="caps">DNA</span> damage. Unfortunately red wine is <em>reported</em> to contain alcohol, which is known to cause <span class="caps">DNA</span> damage.</p>


	<p>It is interesting that, although scientists are always eager to highlight the <em>potential</em> benefits of a discovery, even when the connection is tenuous, it takes a journalist, even more eager to produce a catchy headline, to come with something like this. Are <em>mistakes</em> like this the <strong>necessary</strong> price to pay for making scientific discoveries relevant  to the rest of society?</p>]]>
      </description>
      <pubDate>Sun, 20 Jul 2008 12:28:10 -0000</pubDate>
      <link>http://network.nature.com/blogs/user/basanta/2008/07/20/cancer-wine-and-reporting</link>
      <guid>http://network.nature.com/blogs/user/basanta/2008/07/20/cancer-wine-and-reporting</guid>
      <dc:creator>David Basanta</dc:creator>
    </item>
    <item>
      <title>Talk in Edinburgh on TGF&#223;</title>
      <description>
        <![CDATA[<p><img src="http://www.maths.dundee.ac.uk/~basanta/me.jpg" alt="" /> I am at the European Conference of Mathematical and Theoretical Biology that Dundee&#8217;s group of biomathematics is organising. It&#8217;s a big conference with hundreds of participants and takes place only once every three years.</p>


	<p><img src="http://www.maths.dundee.ac.uk/ecmtb08/images/ecmtb08_poster_small2.png" alt="" /></p>


	<p>I had the privilege to give a small contributed talk on my research with <a href="http://www.maths.dundee.ac.uk/~sanderso/">Sandy Anderson</a> and the guys at <a href="http://network.nature.com/profile/swh">Hayward&#8217;s lab</a> in Vanderbilt. Briefly our model tries to explain the role of stromal-epithelial interactions (mediated via <a href="http://en.wikipedia.org/wiki/TGF_beta">TGFß</a>) in prostate cancer. we found out that while <strong>TGFß</strong> plays an important role in maintaining homeostasis in a healthy tissue and after a tumour has broken out of the acini (that make the prostate), it does not affect much tumour progression while the tumour remains inside the acinus.</p>


	<p>We did also find that more <strong>agressive</strong> tumour cells (like those producing lots of matrix degrading enzymes) are not necessarily going to be more succesful in taking over the prostate tissue.</p>]]>
      </description>
      <pubDate>Thu, 03 Jul 2008 17:18:32 -0000</pubDate>
      <link>http://network.nature.com/blogs/user/basanta/2008/07/03/talk-in-edinburgh-on-tgf%C3%9F</link>
      <guid>http://network.nature.com/blogs/user/basanta/2008/07/03/talk-in-edinburgh-on-tgf%C3%9F</guid>
      <dc:creator>David Basanta</dc:creator>
    </item>
    <item>
      <title>Cloud computing and science</title>
      <description>
        <![CDATA[<p><img src="http://www.maths.dundee.ac.uk/~basanta/me.jpg" alt="" /> One of the hot topics for computer scientists nowadays is <a href="http://en.wikipedia.org/wiki/Cloud_computing">cloud computing</a>. Some good examples of cloud computing are most web 2.0 <em>applications</em> in which the computation and the data reside in a number of servers somewhere in the net, but presenting an interface not different to those of regular desktop applications, all that combined with social features that allow the system to establish relations between the different items of data.</p>


	<p><img src="http://upload.wikimedia.org/wikipedia/en/thumb/4/44/Cloudcomputing.png/800px-Cloudcomputing.png" alt="" /></p>


	<p>Apparently, some people are seeing some potential in cloud computing not just as an aid to science but as a completely new approach to do it. An <a href="http://www.wired.com/science/discoveries/magazine/16-07/pb_theory">article</a> in Wired magazine argues precisely that. With the provocative title of <strong>The end of theory</strong>, the article concludes that,  with plenty of data and clever algorithms (like those developed by Google), it is possible to obtain patterns that could be used to predict outcomes&#8230;and all that without the need of <strong>scientific models</strong>.</p>


	<p>I would start arguing now about how models are just more than predictive machines but people have already stepped up to the challenge. John Timmer at <a href="http://arstechnica.com/news.ars/post/20080625-why-the-cloud-cannot-obscure-the-scientific-method.html">Ars Technica</a> (not a science website either) make some very valid points (in my opinion). Does any one else think that traditional science is a thing of the past and that cloud computing will drive us modelers to the employment office?</p>]]>
      </description>
      <pubDate>Sat, 28 Jun 2008 19:19:38 -0000</pubDate>
      <link>http://network.nature.com/blogs/user/basanta/2008/06/28/cloud-computing-and-science</link>
      <guid>http://network.nature.com/blogs/user/basanta/2008/06/28/cloud-computing-and-science</guid>
      <dc:creator>David Basanta</dc:creator>
    </item>
    <item>
      <title>Cancer and networks</title>
      <description>
        <![CDATA[<p><img src="http://www.maths.dundee.ac.uk/~basanta/me.jpg" alt="" /> I have compared tumours with ecosystems in previous occasions and one thing about ecosystems is that some people try to study and characterise them using networks (or graphs if your background is mathematics).</p>


	<p>Basically that involves selecting <strong>key species</strong> and their <strong>interactions</strong>, be it predator/prey or mutualistic. Once a network is defined, it is possible to study a number of things such as network dynamics and robustness.</p>


	<p>That is because network theory has been used to study all sorts of things including communications networks. Once a network has been laid out it is possible to study how fragile or how resilient it is. How easy is to include new <strong>nodes</strong> or add new links is a fundamental property of a communication network. Network analysis has proven how robust and scalable internet is against most disruptions&#8230;and also how fragile could it be against a determined attack against a few but selected servers.</p>


	<p><img src="http://upload.wikimedia.org/wikipedia/commons/6/68/Social-network.svg" alt="" /></p>


	<p>There are parallels between ecological and non ecological networks. A (not that recent) review paper I recently found in Nature is precisely addressing this parallelisms. The paper is <strong>Ecological Networks and their fragility</strong> by Montoya et al. Nature Vol 422, July 2006. Can be found <a href="http://www.nature.com/nature/journal/v442/n7100/abs/nature04927.html">here</a></p>


	<p>Some interesting things coming out from the paper is that some models suggest that species that have a big overlap in their diets can&#8217;t coexist. So basically if two species depend on basically the same nutrients to survive and live in the same ecosystem, eventually one of them will eventually become <strong>extinct</strong>. On the other hand the effect of one species on the numbers of another diminishes  with the separation in the network or food web.<br />For a cancer I might speculate that this could imply that there is a limit to how many different <em>phenotypes</em> could there be simultaneously in a tumour (feeding on the same nutrients and competing for the same space) but <a href="http://network.nature.com/profile/boboh">Bob</a> points out that the time constraints in which tumour evolution takes place are a better explanation of this potential lack of diversity I predict.</p>


	<p>Unfortunately the paper does not get into the details of how to study the effects of taking down (or adding up) a new node or link in the network in terms of robustness. I am sure it would be very interesting to be able to characterise a tumour ecosystem in terms of a network and then identify nodes (tumour phenotypes) or links (cooperation or predation) that could be potential target for therapy</p>]]>
      </description>
      <pubDate>Mon, 23 Jun 2008 19:32:58 -0000</pubDate>
      <link>http://network.nature.com/blogs/user/basanta/2008/06/22/cancer-and-networks</link>
      <guid>http://network.nature.com/blogs/user/basanta/2008/06/22/cancer-and-networks</guid>
      <dc:creator>David Basanta</dc:creator>
    </item>
    <item>
      <title>Diversity in the Microenvironment and tumour progression</title>
      <description>
        <![CDATA[<p><img src="http://www.maths.dundee.ac.uk/~basanta/me.jpg" alt="" />  Last week&#8217;s <a href="http://www.nature.com/nature/journal/v453/n7195/full/453604a.html">Nature</a> included a brief but interesting review on some recent research on the role of the microenvironment in cancer progression.</p>


	<p>The article starts with the premise (which I certainly share) that a tumour is a collection of different types of cells, some of them tumour cells, that act together towards the progression of the disease. Among these cells there are stromal cells (fibroblasts, endothelial cells, immune cells) whose interactions with abnormal epithelial (tumour) cells can potentially determine tumour progression.</p>


	<p>One of the ways in which this interaction is being studied is through gene expression profiles. Although the precise mechanisms might be unknown, certain patters of gene expression can be associated with specific tumour outcomes. Also there are a number of pathways in the epithelial cells that are related to the response to signalling from stromal cells, whose disruption can lead to tumour invasion of the basement membrane.</p>


	<p>Studies like the ones covered in this review provide an alternative view of that in which tumour progression is exclusively characterised by a number of genetic mutations. Not only the path of the tumour progression depends on interactions with the microenvironment but the <strong>diversity</strong> of this microenvironment in general and some <strong>stromal</strong> cell types in particular could potentially have a big impact on that path. A key element could be the <a href="http://en.wikipedia.org/wiki/Coevolution"><strong>coevolution</strong></a> between the tumour cells and those in the stroma.</p>


	<p>Saying that the stroma influences tumour evolution by contributing to select some tumour phenotypes over others is unlikely to be a controversial statement. But this influence could also work the other way around and it is an intriguing hypothesis: if there is evolution in some <em>key</em> stromal cell types like fibroblasts, what kind of evolution would that be? and if it is meaningful, how tumour evolution influences stromal evolution and viceversa?.</p>


	<p>The notion of stromal evolution demands some explanation. At the end of the day evolution requires a number of <em>ingredients</em> that most people would not expect to find in healthy mammalian cells (asides from those of the immune system). Specifically, asides from the already mentioned diversity, evolution needs that some of the phenotypes have <strong>higher fitness</strong> than others. A high degree of fitness in a phenotype should lead to more individuals of the same phenotype. This is normally acomplished by means of <strong>differential reproduction</strong> by which fitter individuals, in the long run, tend to produce more offspring than the less fit ones.</p>


	<p>Not wanting to turn this into a philosophical post, I will just mention that I was recently discussing with friends about stromal evolution when I was suggested that, maybe, this <em>differential reproduction with inheritance</em> is not that indispensable as I once thought. At least in the context of somatic evolution in mammalian  cells where there is a limit to how much time evolution has to get things changed and where there cells are endowed with certain <strong>phenotypic plasticity</strong> (mainly constrained by environmental signals). The idea then would be that <em>somatic</em> evolution of fibroblasts proceeds as some of them change their phenotypic profile (probably in response to signals sent by tumour cells) and influence other fibroblasts to adopt theirs. This, in return, would alter the microenvironment in such a way as to affect the tumour and also the fibroblasts themselves, maybe triggering the emergence of a different phenotypic profile.</p>]]>
      </description>
      <pubDate>Sun, 15 Jun 2008 12:16:03 -0000</pubDate>
      <link>http://network.nature.com/blogs/user/basanta/2008/06/12/diversity-in-the-microenvironment-and-tumour-progression</link>
      <guid>http://network.nature.com/blogs/user/basanta/2008/06/12/diversity-in-the-microenvironment-and-tumour-progression</guid>
      <dc:creator>David Basanta</dc:creator>
    </item>
    <item>
      <title>Play it again, Charles</title>
      <description>
        <![CDATA[<p><img src="http://www.maths.dundee.ac.uk/~basanta/me.jpg" alt="" /> So what if we could replay evolution and see how different things would be? Evolutionary logic dictates that things could potentially be quite different since, many times, little random events can have important long term consequences. People that have worked designing <strong>evolutionary algorithms</strong>, like <a href="http://en.wikipedia.org/wiki/Genetic_algorithm">genetic algorithms</a> (the only acceptable combination of design and evolution in a single sentence that I can think of) already know that multiple runs of the same simulation configuration can lead to different results. People working on evolutionary algorithms don&#8217;t normally allow for <strong>open ended</strong> evolution, meaning that they normally have an idea of the outcome they would like to get, which severely limits the number of possible evolutionary paths. Despite that, my experience with evolutionary algorithms tells me that different executions will produce different results through different evolutionary paths.</p>


	<p>But one thing is theory or computing, and a different one is a colony of bacteria as, say, E. coli. Now, that would be an interesting experiment&#8230;if it wasn&#8217;t because it has already been <a href="http://scienceblogs.com/loom/2008/06/02/a_new_step_in_evolution.php">done</a>! <a href="http://www.sciencenews.org/view/generic/id/32801/title/Replaying_evolution_">ScienceNews</a> reports about this experiment performed at Michigan State University&#8217;s Lenski&#8217;s <a href="https://www.msu.edu/~lenski/">Lab</a>.</p>


	<p>The work has been described at length in <a href="http://www.pnas.org/cgi/content/abstract/0803151105v1">PNAS</a> this week.</p>


	<p>Lenski and colleagues collected samples of the bacteria  of, initially, identical E.coli in 12 colonies, every 500 generations for <strong>20 years</strong> (!!!). This represents 40000 generations of bacteria. Not entirely unexpectedly each colony followed a different path, in one case significantly deviating from the original type. In the 12th colony, bacteria eventually evolved the ability to use a nutrient that the regular kind can&#8217;t absorb. Observing this, the researchers took a number of samples of earlier generations and the more remote the starting point, the smaller the likelihood of the colony to re-evolve that ability. At some point, going back to restart evolution stopped yielding the bacteria capable of absorbing new nutrients which hinted the evolutionary period in which the crucial genetic innovation was introduced.</p>


	<p>Of course it is not that every colony went in an entirely different way and some of the dynamics were rather <strong>predictable</strong>. Such as that bacterial colonies got predictably better at absorbing their usual nutrients and dividing faster. So given a non harsh environment and enough colonies I guess is not difficult to foresee some trends.</p>]]>
      </description>
      <pubDate>Fri, 06 Jun 2008 22:03:02 -0000</pubDate>
      <link>http://network.nature.com/blogs/user/basanta/2008/06/06/play-it-again-charles</link>
      <guid>http://network.nature.com/blogs/user/basanta/2008/06/06/play-it-again-charles</guid>
      <dc:creator>David Basanta</dc:creator>
    </item>
    <item>
      <title>Vaccinating against glioblastomas</title>
      <description>
        <![CDATA[<p><img src="http://www.maths.dundee.ac.uk/~basanta/me.jpg" alt="" /> Today I found this while browsing <a href="http://www.economist.com/science/displaystory.cfm?story_id=11449797">The Economist</a> in a bookstore in Dundee. Some time ago researchers found that cervical cancer is produced by a virus. This raises the interesting question of <strong>what is the proportion and nature of the cancers that are initiated by a virus</strong>.</p>


	<p>More recently researchers in San Francisco found something interesting about glioblastomas, one of the most deadly types of cancer that originates in the glial cells in the brain.</p>


	<p><img src="http://upload.wikimedia.org/wikipedia/en/c/c3/Neuroglia.png" alt="" /></p>


	<p>Whether glioblastomas are initiated by a virus or not is not clear, but these researchers found that in most cases (90%) the abnormal glial cells contain cytomegalovirus. This finding has been taken up by researchers at Duke who have designed a vaccine designed to train the immune system to recognise and target cells that contain this virus. Since the process of training one&#8217;s immune system to recognise viruses is rather well understood and given that killing the glial cells with a virus will kill all tumour cells that looks like a promising idea. Preliminary results seem to be good, let&#8217;s keep fingers crossed!</p>]]>
      </description>
      <pubDate>Mon, 02 Jun 2008 19:11:58 -0000</pubDate>
      <link>http://network.nature.com/blogs/user/basanta/2008/06/01/vaccinating-against-glioblastomas</link>
      <guid>http://network.nature.com/blogs/user/basanta/2008/06/01/vaccinating-against-glioblastomas</guid>
      <dc:creator>David Basanta</dc:creator>
    </item>
    <item>
      <title>The end of cancer in sight?</title>
      <description>
        <![CDATA[<p><img src="http://www.maths.dundee.ac.uk/~basanta/me.jpg" alt="" /> I would say that this is a rather controversial statement to make but one of the world&#8217;s cancer biologists, Sloan-Kettering&#8217;s <a href="http://www.mskcc.org/mskcc/html/10614.cfm">Joan Massague</a> may have just suggested something close to that in a talk he gave at my <a href="http://www.uniovi.es">alma mater</a>.</p>


	<p>Unfortunately I haven&#8217;t found an English source for this piece of news but those of you that can cope with Spanish can follow it <a href="http://www.lne.es/secciones/noticia.jsp?pRef=2008052400_46_639570__SociedadyCultura-Massague-Hemos-entrado-fase-conquista-definitiva-cancer">here</a></p>


	<p><img src="http://www.mskcc.org/mskcc/_assets/content-image/382473.jpg" alt="" /></p>


	<p>Massague believes that the first half of this century, thanks to past and ongoing efforts in so many fronts of cancer research (chemotherapy, personalised medicine, genomics&#8230;I assume that he forgot to mention mathematical oncology?) will transform cancer into a disease with a prognosis not too different from that of cardiovascular diseases. He also mentioned cancer as a disease with at least <strong>300 variants</strong> so I imagine that some of them will be easy to tackle while others will keep cancer researchers busy for quite a few more decades.</p>]]>
      </description>
      <pubDate>Tue, 27 May 2008 20:40:42 -0000</pubDate>
      <link>http://network.nature.com/blogs/user/basanta/2008/05/27/the-end-of-cancer-in-sight</link>
      <guid>http://network.nature.com/blogs/user/basanta/2008/05/27/the-end-of-cancer-in-sight</guid>
      <dc:creator>David Basanta</dc:creator>
    </item>
    <item>
      <title>Meeting in Turin</title>
      <description>
        <![CDATA[<p><img src="http://www.maths.dundee.ac.uk/~basanta/me.jpg" alt="" /> I have not posted a lot in the last couple of months. During april I went to the US to visit some <a href="http://www.vicc.org/research/display.php?id=3997">biologists</a> at Vanderbilt where we study the role of <a href="http://www.vicc.org/research/programs/host.php">stroma-epithelia</a> interactions on prostate cancer both computationally and (hopefully soon) experimentally. This month I attended <a href="http://cancersim2008.org/">CancerSim 2008</a> in Turin, Italy. Following the wishes of <a href="http://network.nature.com/blogs/user/mfenner/2008/05/17/scientific-meetings-need-more-bloggers">Martin Fenner</a> I will talk about the meeting.</p>


	<p><a href="http://cancersim2008.org/">CancerSim</a> was the last meeting of the <a href="http://calvino.polito.it/~mcrtn/">Marie Curie Research Network</a> established to put together mathematical oncologists in Europe. Since many of the network organisers are in Turin the meeting took place in Turin. As you can see in the photo</p>


	<p><img src="http://farm4.static.flickr.com/3215/2524297786_2f619c6144.jpg" alt="" /></p>


	<p>Turin is a very pretty city full of history, friendly people, great food, wine and coffee&#8230;.and some times not as sunny as one would expect Italy to be when travelling from Scotland.</p>


	<p>The programme of the conference was the usual in these meetings, with many mathematicians (with different degrees of bio attached to their research) and some biologists (with also different degrees of interest in mathematical/computational formalisations). Asides from the separation between mathematicians and biologists (that I&#8217;d say this network helped to bridge somewhat) there was also the gap between young and established researchers. Young researcher meaning, of course, those of us with temporal contracts. But this is not a critic, one good thing about the network was the amount of travelling, exchanges and long stays between the different groups that make the network. It is difficult to explain but all this frantic travelling allowed us to get an overview of what is there in terms of mathematical/theoretical oncology in Europe. It also started many collaborations, especially between the <em>young researchers</em> (which I think is much easier in theoretical fields than in experimental ones since often times you need little more than a laptop, a notebook and a pen). I wonder if they have similar programmes in the <span class="caps">US </span>(or other parts of the world), seems to me that any government interested in science would have  not that many other investment opportunities that would give the same bang for the euro.</p>]]>
      </description>
      <pubDate>Mon, 26 May 2008 11:57:11 -0000</pubDate>
      <link>http://network.nature.com/blogs/user/basanta/2008/05/25/meeting-in-turin</link>
      <guid>http://network.nature.com/blogs/user/basanta/2008/05/25/meeting-in-turin</guid>
      <dc:creator>David Basanta</dc:creator>
    </item>
    <item>
      <title>Locust and tumour invasion</title>
      <description>
        <![CDATA[<p><img src="http://www.maths.dundee.ac.uk/~basanta/me.jpg" alt="" /> Via an article I found this morning in the <a href="http://news.bbc.co.uk/1/hi/sci/tech/7395356.stm">BBC</a> I found about a recent piece of research about locust published in <a href="http://www.sciencedirect.com/science?_ob=ArticleURL&#38;_udi=B6VRT-4SF9GJ0-8&#38;_user=1669875&#38;_rdoc=1&#38;_fmt=&#38;_orig=search&#38;_sort=d&#38;view=c&#38;_acct=C000054131&#38;_version=1&#38;_urlVersion=0&#38;_userid=1669875&#38;md5=5af1a253ad6c30bd5270d03cee836cef">Current Biology</a> abo .</p>


	<p>Interestingly it seems that the reason that locusts combine into swarms is out of fear of being eaten by other locusts. Although locust are normally herbivore, when food becomes scarce some of them might resort to cannibalism.</p>


	<p><img src="http://upload.wikimedia.org/wikipedia/commons/e/e9/Acrididae_grasshopper-2.jpg" alt="" /></p>


	<p>And that is interesting in the sense that these highly <strong>aggressive</strong> (from the way they travel and eat) swarms are made of the less aggressive individuals that band together and escape from the cannibals, with <strong>devastating</strong> consequences. This is rather similar to what some researchers are finding in tumours, both experimentally and theoretically. As was discussed in previous posts (<a href="http://cancerevo.blogspot.com/2007/04/back-from-scotland-and-gatenbys-talk.html">here</a> or <a href="http://cancerevo.blogspot.com/2006/12/gatenby-and-smallbone-glycolysis-and.html">here</a> for instance) reverting to a glycolytic metabolism allows tumour cells to survive in environments poor in oxygen while harming their neighbours. It has been hypothesised that motile tumour cells are more likely to appear if there is an increase in the acidity of the environment, in many cases as a consequence of the existence of these glycolytic cells (I should give a disclaimer and say that one of my papers is devoted to study this using game theory). Could it be a <strong>similar</strong> phenomena? that is, that less aggressive cell types escape from the more aggressive ones and that the consequence is also devastating (since these motile cells are responsible for the invasion and metastasis that characterise the last stages in cancer). Probably not very useful as an analogy: I am not sure how these researchers measured the <em>fear</em> of locust to their cannibal colleagues  but it is safe to assume that tumour cells do not have much of that. Still fear is an instinct for self preservation that has a parallel in the microcosms of a tumour.</p>]]>
      </description>
      <pubDate>Mon, 12 May 2008 18:52:15 -0000</pubDate>
      <link>http://network.nature.com/blogs/user/basanta/2008/05/12/locust-and-tumour-invasion</link>
      <guid>http://network.nature.com/blogs/user/basanta/2008/05/12/locust-and-tumour-invasion</guid>
      <dc:creator>David Basanta</dc:creator>
    </item>
    <item>
      <title>The cost of intelligence</title>
      <description>
        <![CDATA[<p><img src="http://www.maths.dundee.ac.uk/~basanta/me.jpg" alt="" /> Browsing the New York Times online today I found <a href="http://www.nytimes.com/2008/05/06/science/06dumb.html?pagewanted=1&#38;ei=5087&#38;em&#38;en=5ad8860720a71de7&#38;ex=1210305600">this</a> interesting article (and a related <a href="http://www.nytimes.com/2008/05/07/opinion/07wed4.html?ref=opinion">editorial</a>).</p>


	<p>Intelligence is one of these fuzzy concepts that are so difficult to define formally. We all have some intuitive idea of what it is to be intelligent and in most cases involves some capability to solve new problems and learn from past experiences. So, it is intelligence something unavoidable in evolutionary terms? and, as the article asks, <strong>if intelligence is something so great why is it that you don&#8217;t find it in most species?</strong></p>


	<p>It is important to make clear that most &#8216;complex&#8217; species have some degree of intelligence and that even fruit flies are capable of learning. According to the article, most species with a nervous system (and some without them, just using their genetic <strong>network</strong>, and network is here the keyword) can behave non instinctively.</p>


	<p><img src="http://upload.wikimedia.org/wikipedia/commons/5/50/Drosophila-melanogaster-Nauener-Stadtwald-03-VII-2007-12.jpg" alt="" /></p>


	<p>What is more interesting, it is possible to obtain <em>smarter</em> flies by selecting, in a lab,  for those individuals that are more capable of learning. In only 15 generations the researchers found that the flies have evolved to learn faster. So why don&#8217;t you see smarter flies in the wild? When you mix these &#8216;smarter&#8217; flies with the original kind they found that the smarter kind where less likely to survive. Actually when the &#8216;smart&#8217; flies were places in a nutrient-poor environment and allowed to evolve the researchers found that after 30 generations the flies were <em>less clever</em>. It seems that brains come with a price tag and it might be that only very specific environments lead to a <strong>selective pressure</strong> that could make a complex neural system such as ours (that consumes 20% of all calories burned at rest) something worth investing in. It should be also an environment in which non specialised agents can buy enough time to learn and improve.</p>]]>
      </description>
      <pubDate>Wed, 07 May 2008 18:52:21 -0000</pubDate>
      <link>http://network.nature.com/blogs/user/basanta/2008/05/07/the-cost-of-intelligence</link>
      <guid>http://network.nature.com/blogs/user/basanta/2008/05/07/the-cost-of-intelligence</guid>
      <dc:creator>David Basanta</dc:creator>
    </item>
    <item>
      <title>Science editorial: cancer and apoptosis</title>
      <description>
        <![CDATA[<p><img src="http://www.maths.dundee.ac.uk/~basanta/me.jpg" alt="" /> A relatively new issue of <a href="http://www.sciencemag.org/cgi/content/full/320/5872/19">Science</a> (4th of April this year) has an interesting editorial about the value of cancer research.</p>


	<p>He claims that some people would like to see the money that is invested in the most fundamental of cancer research directly into the design of treatments and therapies. Something like <em>we know enough about Cancer so let&#8217;s stop wasting time and money and let&#8217;s start doing things with what we already know</em>. That is for me a rather surprising attitude: since I started working with cancer researchers what I found most surprising is not the amount of things we know, but the opposite, <em>how little do we know</em> after all the time and money invested in research. This is, of course, not the fault of cancer scientists but more the result of the extreme and incredible complexity of cancer as a disease. If there is something we need now is more fundamental research, and if you keep asking me, more theoretical research so we can knit all this knowledge into a cohesive set of laws.</p>


	<p>Bruce Alberts, Science&#8217;s editor in chief describes examples of how a better understanding of the fundamental mechanisms could go a long way on improving cancer therapies. Specifically he mentions <strong>apoptosis</strong> and <strong>DNA repair</strong> which he identifies as two of the most promising areas of research with a potential impact in treating cancer.</p>


	<p>The importance of the first one is not difficult to grasp. Cells in multi cellular organisms have a tendency to commit something akin to suicide and only constant reassurances from the environment that they are doing ok prevent them from doing so. Avoiding apoptosis is one of the most important milestones of a tumour cell, otherwise its chance of provoking havoc is somewhat limited.</p>


	<p>The second mechanism is less straight forward in my opinion. A flawless <span class="caps">DNA</span> repair mechanism should prevent harmful mutations in the first place and will lead to apoptosis if the reparation is not doable. Thus a tumour cell should aim to have a less than perfect <span class="caps">DNA</span> repair mechanism in order to accumulate the necessary genetic mutations. For that exact same reason, a therapy that could re establish the functionality of the <span class="caps">DNA</span> repair mechanism would go a long way in making sure that abnormal cells die (due to apoptosis) whereas healthy cells stay.</p>


	<p>These two are only a sample of things that the author argues we don&#8217;t know well and which deserve ample funding even when the hope of getting a therapy out of the money invested is not in the short term. I&#8217;d argue that I know a few more areas worth investing on but that might not be entirely unbiased&#8230;</p>]]>
      </description>
      <pubDate>Thu, 17 Apr 2008 11:28:59 -0000</pubDate>
      <link>http://network.nature.com/blogs/user/basanta/2008/04/17/science-editorial-cancer-and-apoptosis</link>
      <guid>http://network.nature.com/blogs/user/basanta/2008/04/17/science-editorial-cancer-and-apoptosis</guid>
      <dc:creator>David Basanta</dc:creator>
    </item>
    <item>
      <title>Gatenby and Gillies: A microenvironmental model of carcinogenesis</title>
      <description>
        <![CDATA[<p><img src="http://www.maths.dundee.ac.uk/~basanta/me.jpg" alt="" /> Giving the finishing touches to a paper which I am writing with people in Dresden and Lyon, I came across an interesting article:</p>


	<p>R. Gatenby and R. Gillies. <a href="http://www.nature.com/nrc/journal/v8/n1/abs/nrc2255.html">A microenvironmental model of carcinogenesis</a>. Nature Reviews Cancer 8, 56-61 (2008)</p>


	<p>Neither Gatenby nor Gillies are mathematicians (the first is a physician whereas the second is a biologist) but both have worked before on some rather interesting models of carcinogenesis. In this paper they again introduced one of their models, constructed around a differential equation with a Lotka-Volterra term, in order to study how the microenvironment contributes to select phenotypical traits (conferred by genetic mutations).</p>


The phenotypical traits are:
	<ul>
	<li>Insensitivity to anti growth signals.</li>
		<li>Self sufficiency in growth signals.</li>
		<li>Limitless replication.</li>
		<li>Abnormally high glucose uptake</li>
		<li>Resistance to acid mediated toxicity</li>
		<li>Invasion and metastases with sustained angiogenesis</li>
	</ul>


	<p>This list is very similar to the one proposed by <a href="http://www.cell.com/content/article/abstract?uid=PIIS0092867400816839">Hanahan and Weinberg</a> (which long time readers of this blog might be familiar with). The biggest difference is the emphasis on acidity and glucose consumption, stuff related with the glycolytic metabolism, whose importance in tumour progression has been championed by Gatenby.</p>


	<p>This is very relevant research and the authors do well to point out that most cell-centric models study tumour progression without questioning much why specific phenotypical changes are necessary. The answer is of course in the microenvironment, that allows those phenotypes that are better adapted to survive and grow. Microenvironental features represent barriers that limit tumour growth and thus, the phenotypes that manage to overcome them (whatever the genetic or epigenetic mechanism they exploit) will prosper, probably at the expense of the less adapted phenotypes.</p>]]>
      </description>
      <pubDate>Sat, 12 Apr 2008 18:06:28 -0000</pubDate>
      <link>http://network.nature.com/blogs/user/basanta/2008/04/12/gatenby-and-gillies-a-microenvironmental-model-of-carcinogenesis</link>
      <guid>http://network.nature.com/blogs/user/basanta/2008/04/12/gatenby-and-gillies-a-microenvironmental-model-of-carcinogenesis</guid>
      <dc:creator>David Basanta</dc:creator>
    </item>
    <item>
      <title>The role TGF-Beta in tumour metastasis</title>
      <description>
        <![CDATA[<p><img src="http://www.maths.dundee.ac.uk/~basanta/me.jpg" alt="" /> As I am working on a project to study the role of <span class="caps">TGF</span>-Beta in prostate tumour progression (see more on an older <a href="http://network.nature.com/blogs/user/basanta/2008/01/14/facts-about-prostate-cancer">post</a>), everything <span class="caps">TGF</span>-Beta related catches my attention.</p>


	<p>The Transforming Growth Factor Beta (or just <span class="caps">TGFB</span>) are a family of proteins that control cell proliferation and differentiation. I hope that my friends at Vanderbilt will correct me if they don&#8217;t agree with the statement that <em>an imbalance in <span class="caps">TGFB</span> production and consumption could lead to uncontrolled growth</em> and potentially to the beginning of a tumour.</p>


	<p>Now, a group of researchers from New York and Barcelona led by Joan Massague have shown how <span class="caps">TGFB</span> plays also an important role <strong>by improving the chances of tumour cells originated in the breast to better to metastasise in the lung</strong> (although, curiously not in the bone). The research is reported in this week&#8217;s <a href="http://www.cell.com/content/article/fulltext?uid=PIIS0092867408002110">issue of Cell</a> (as well as in the <a href="http://www.elmundo.es/elmundosalud/2008/04/03/oncologia/1207223937.html">Spanish press</a> for those of you that speak Spanish).</p>


	<p>The research shows that <span class="caps">TGFB</span> allows cells to depart the primary tumour and empowers to disrupt the walls of capillaries in the lung vastly improving their chances of establishing a new tumour colony.</p>]]>
      </description>
      <pubDate>Mon, 07 Apr 2008 16:31:00 -0000</pubDate>
      <link>http://network.nature.com/blogs/user/basanta/2008/04/07/the-role-tgf-beta-in-tumour-metastasis</link>
      <guid>http://network.nature.com/blogs/user/basanta/2008/04/07/the-role-tgf-beta-in-tumour-metastasis</guid>
      <dc:creator>David Basanta</dc:creator>
    </item>
    <item>
      <title>More about drinks</title>
      <description>
        <![CDATA[<p><img src="http://www.maths.dundee.ac.uk/~basanta/me.jpg" alt="" /><br />Since the last topic about drinks was so popular among some of my friends (which makes most of the readership of this blog anyway), now I continue with something I read today at the <a href="http://news.bbc.co.uk/1/hi/health/7326839.stm">BBC&#8217;s website</a>. Researchers at the University of North Dakota have found that caffeine can act as a blood flood barrier and thus protect the brain from some of the harmful elements that are present in the bloodstream (not all of it made of oxygen, immune cells and other desirable things). The research, tested on rabbits and published at the <a href="http://www.jneuroinflammation.com/content/5/1/12">Journal of Neuroinflammation</a>, suggests that one cup of coffee a day (or its equivalent in terms of caffeine) might help to prevent Alzheimer. And if it is good enough for a rabbit, then it is good enough for me!</p>


	<p>Now, if you excuse me, I am off to get an espresso.</p>


	<p><span class="caps">UPDATE</span>: Seems that neither beer <a href="http://news.bbc.co.uk/1/hi/health/7326437.stm">nor water</a> are that good for you. I am off for another ristretto.</p>]]>
      </description>
      <pubDate>Thu, 03 Apr 2008 11:25:27 -0000</pubDate>
      <link>http://network.nature.com/blogs/user/basanta/2008/04/03/more-about-drinks</link>
      <guid>http://network.nature.com/blogs/user/basanta/2008/04/03/more-about-drinks</guid>
      <dc:creator>David Basanta</dc:creator>
    </item>
    <item>
      <title>Beer and science</title>
      <description>
        <![CDATA[<p><img src="http://www.maths.dundee.ac.uk/~basanta/me.jpg" alt="" /> Bad news for those of us that believe that a pint (some might say that a pint is only a promising start) after a long day&#8217;s work is only a nice way to chill out and recharge batteries for the next day (of more hard work?). According to a study published in <a href="http://www.blackwell-synergy.com/action/showFullText?submitFullText=Full+Text+HTML&#38;doi=10.1111%2Fj.2008.0030-1299.16551.x&#38;cookieSet=1">Oikos</a> , consumption of beer correlates with scientific productivity  ... and not in the way that some of us would hope for. Moreover, the study comes from Czech scientists. The Czech republic is said to have the highest per capita consumption of beer in the world. So if Czech researchers say that beer is not good for scientists, they certainly have written this with a heavy heart.</p>


	<p>Basically the research shows that publication success is correlated, in the fields of behavioural and evolutionary ecology in the Czech republic, and that this correlation happens even when the subject of research drank only a glass (and more so when they drink more than that). This correlation is negative so the more they drink the poorer the publication record.</p>


	<p>I found this research mentioned in the <span class="caps">NYT</span> and one of the comments was (not entirely unexpected) that correlation is not causation and that beer drinking might not be responsible for poor academic success but probably the other way round: poor academic success leads researchers to drink more. I for one keep my fingers crossed that these people don&#8217;t start studying now the influence of red wine. Some times ignorance is bliss&#8230;</p>


	<p><span class="caps">UPDATE</span>: Apparently (and unsurprisingly) <a href="http://life.lithoguru.com/index.php?itemid=119">not everybody agrees</a> with the methodology and conclusions of this paper.</p>]]>
      </description>
      <pubDate>Sun, 23 Mar 2008 18:02:04 -0000</pubDate>
      <link>http://network.nature.com/blogs/user/basanta/2008/03/23/beer-and-science</link>
      <guid>http://network.nature.com/blogs/user/basanta/2008/03/23/beer-and-science</guid>
      <dc:creator>David Basanta</dc:creator>
    </item>
    <item>
      <title>Evolution and drug ressistance</title>
      <description>
        <![CDATA[<p><img src="http://www.maths.dundee.ac.uk/~basanta/me.jpg" alt="" /> Two articles from a recent issue of nature (<a href="http://www.nature.com/nature/journal/v451/n7182/abs/nature06548.html">[here</a> and <a href="http://www.nature.com/nature/journal/v451/n7182/abs/nature06633.html">[here]</a>) raise the issue of how genetic diversity may affect anti-tumour chemotherapies. A nice overview of the significance of these articles in the grander scale is also provided <a href="http://www.nature.com/nature/journal/v451/n7182/full/4511066a.html">[here]</a>.</p>


	<p>The two papers mention research that could be included in the nascent field of pharmacogenomics in which scientists study how genetic variation (like the one found in a typical tumour) affects the response to a drug in terms of efficacy or toxicity. And of course it seems that this diversity has a huge and rather negative impact on the efficacy of the drugs. When a particular cancer gene can have its effect duplicated by a mutation in a different gene then a therapy that targets cells with the first type of mutation are effectively selecting for cells with the second kind. This is not necessarily a bad thing but at least should be taken on account before pursuing any option. If selecting for a tumour composed by this second alternative mutation leads to a tumour that is effectively easier to treat then the treatment is a good one. But it could also happen that things go the other way and a drug helps the tumour evolve towards malignancy.</p>


	<p>One way to stop tumour (somatic) evolution is to target more than one mutant simultaneously, although this also makes it more likely that there will be side effects that will be felt by healthy cells. A different approach has been announced <a href="http://dsc.discovery.com/news/2008/03/10/virus-brain-cancer.html">recently</a>. This approach fights evolution with evolution with a virus that helps to fight brain tumour cells. This is an exciting development that is being currently used by researchers in Yale to treat very serious cases in a type of tumour, brain tumours, in which tumour growth happens very rapidly and in which surgery is very complicated. In any case one is left wondering what will stop the virus to evolve to attach healthier cells once the tumour cells it lived on start being scarce.</p>]]>
      </description>
      <pubDate>Wed, 19 Mar 2008 23:45:16 -0000</pubDate>
      <link>http://network.nature.com/blogs/user/basanta/2008/03/19/evolution-and-drug-ressistance</link>
      <guid>http://network.nature.com/blogs/user/basanta/2008/03/19/evolution-and-drug-ressistance</guid>
      <dc:creator>David Basanta</dc:creator>
    </item>
    <item>
      <title>Mistakes and evolution</title>
      <description>
        <![CDATA[<p><img src="http://www.maths.dundee.ac.uk/~basanta/me.jpg" alt="" /> I do follow some scienceblogs out there. The New York Times hosts one from Olivia Judson called <a href="http://judson.blogs.nytimes.com/">The Wild Side</a> about evolutionary biology. The blog is very well written, which is not surprise coming from a professional writer (and research fellow at Imperial College London). The entry a few days ago was about <a href="http://judson.blogs.nytimes.com/2008/02/26/evolving-mistakes/">the role of mistakes in evolution</a>. The mistakes she was writing about are the mutations that occur duplicating the genetic material during cell division.</p>


	<p>What she argues is that mutations are not necessarily an imperfection of our reproductive system but, especially in <strong>asexual species</strong>, the means for adaptation. The claim gets more interesting because, if a given rate of mutations is something that allows <strong>adaptation</strong>, then the mutation rate itself could be subject to adaptation. Turns out that this is true. As I had read before somewhere <a href="http://complex.upf.es/~josep/Infocatast.pdf">else</a> and as I blogged about before when talking about the <a href="http://cancerevo.blogspot.com/2007/01/darwinian-perspective-mutator-phenotype.html">mutator phenotype hypothesis</a>, the mutation rate adapts itself in order to suit the particular environment in which the evolving system lives (I&#8217;d rather call it evolving system since <strong>RNA viruses</strong> are not normally considered living beings). Thus in difficult environments it pays off to have a higher rate of mutation so that a viable phenotype will be found quickly even at the cost of having to produce plenty of absolutely inviable phenotypes at the same time. In nicer environments where many alternative phenotypes can survive then, a high mutation rate is more likely to be <strong>counter productive</strong>.</p>


	<p>These facts should be applicable to cancer. The rate of mutation can be altered by changes in the <span class="caps">DNA</span> repair machinery and the various checkpoints in the cell cycle. Some cells with perfectly functioning <span class="caps">DNA</span> repair mechanisms are unlikely to divide producing mutations along the way. Others with mutations in, say, p53, are more likely to make mistakes during mitosis. As a consequence, someone correct me if I am wrong here, it should be reasonable to expect that tumour cells in those parts of a  tumour that inhabit harsh micro-environments, <strong>should have a higher rate of mutation</strong>. This higher rate of mutation should be the result not only of the fact that tumour cells keep accumulating genetic aberrations but more importantly, from the fact that those cells in harsh environments that insist in keeping a well oiled and preserved division mechanism will be less likely to adapt and  survive. Seems like an interesting problem that could be formulated in terms of mathematical biology.</p>]]>
      </description>
      <pubDate>Thu, 06 Mar 2008 23:46:59 -0000</pubDate>
      <link>http://network.nature.com/blogs/user/basanta/2008/03/06/mistakes-and-evolution</link>
      <guid>http://network.nature.com/blogs/user/basanta/2008/03/06/mistakes-and-evolution</guid>
      <dc:creator>David Basanta</dc:creator>
    </item>
    <item>
      <title>Science in Spain</title>
      <description>
        <![CDATA[<p><img src="http://www.maths.dundee.ac.uk/~basanta/me.jpg" alt="" /> As a Spaniard doing research abroad I feel I should have an opinion of the state of Spanish science. On the other hand I feel I have a more solid experience of the state of Science in places like the UK or Germany than in my own country.</p>


	<p>For that reason I am always happy to read and listen to people and publications that discuss the potential of Spanish research in relation to that of the leading Scientific countries of the world. One of the things that, in my opinion, is easier to have when you see things from afar is a slightly more impartial view. According to reports like <a href="http://www.nature.com/nature/journal/v430/n6997/full/430311a.htmlpublished">this</a> a few years ago in Nature and authored by David King (then the chief advisor to the British government in scientific issues) Spain is far from being the worst place in the world to do science but neither is close enough to be an ideal destination. Good science is possible if you work hard and refuse to submit to burocracy and all the organisational mechanisms designed to keep in the conformists and out the rest. I know some Spanish scientists and I know that it is possible to produce good research but I also suspect that any of them would have had a much easier life if they had decided to move to a different place.</p>


	<p>The <a href="http://www.nature.com/nature/journal/v451/n7182/full/4511029a.html">editorial</a> in this week&#8217;s Nature on occasion of the coming general elections seems to point in that direction too. It mentions the efforts of the current administration significantly increasing the proportion of the <span class="caps">GDP</span> invested in Science which now has reached the level of 1.1% (which is clearly well bellow the quantity and quality invested by many EU countries, let alone Japan or the US). It also mentions what remains to be done which is to restructure the R&#38;D of Spain and especially the main research council, the <a href="http://www.csic.es">CSIC</a>, so as to make sure that the new money that has arrived (and that should keep arriving) will reward the best scientific projects and the best researchers.</p>


	<p>It is quite remarkable that the article keeps referring to a future  silver age: as opposed to the cultural front, Spain has never been part of the scientific elite. In any case, with all this time smelling bronze, silver should be a welcomed change.</p>]]>
      </description>
      <pubDate>Wed, 27 Feb 2008 19:01:09 -0000</pubDate>
      <link>http://network.nature.com/blogs/user/basanta/2008/02/27/science-in-spain</link>
      <guid>http://network.nature.com/blogs/user/basanta/2008/02/27/science-in-spain</guid>
      <dc:creator>David Basanta</dc:creator>
    </item>
    <item>
      <title>About evolution...the theory</title>
      <description>
        <![CDATA[<p><img src="http://viking.mech.kcl.ac.uk:51515/~david/me.jpeg" alt="" /> In the last few days it seems that every where I look there is something about evolution. And I mean it in the sense of Darwinian evolution explicitly stated and talked about, not just in the sense that I see things throughout the glasses of Darwin.</p>


	<p>First thing is that The Guardian, a well known paper in the UK, released 10 days ago in the Saturday edition what they call <strong>The definitive guide to the book that changed the world</strong>. The book is <strong>On the origin of Species</strong> by Darwin and the introduction comes from Richard Dawkins. The booklet contains extracts from the book and the interpretation of the book idea&#8217;s nowadays. A worthy and easy read and came free with my favourite British newspaper.</p>


	<p>Second, a friend in Nashville (hi Simon!) sent me a couple of days ago a <a href="http://www.sciencemag.org/cgi/content/full/316/5830/1427">review in Science</a> (and also a comment in another <a href="http://scienceblogs.com/goodmath/2007/05/behes_dreadful_new_book_a_revi_1.php">blog</a>) about <strong>Behe</strong>&#8217;s rather infamous book &#8220;The Edge of evolution&#8221;. I am quite keen on reading books coming from people that argue against and in favour of evolution but the reviews (and comments from people I know that had read it) are quite discouraging and although the book claims to contain a mathematical proof of the unlikelihood of evolution to produce the diversity and complexity of what biology studies, a mathematical proof is only as good as the assumptions on which it is based. Behe, according to these reviewers, seems to make many mistakes with assumptions that render his proof useless. His point being that <strong>genetic mutations</strong> that actually contribute to an improvement of the fitness of the individual are necessarily improbable.</p>


	<p>People accuse Behe of many things, including giving <em>weapons</em> to religious fundamentalists that might not be interested in science and reason but might just pick whatever supports their ideologies (I won&#8217;t use the word <em>idea</em> here) and advance their cause. Truth is, though, that Behe seems to at least accept that the world is older than just a few thousand years and that variation, heredity and natural selection account for some of the diversity in nature. His mathematical proof is likely to be wrong and based on wrong assumptions but so are many of the ideas presented by many scientists. Good thing about science is that, with time and accumulation of evidence, the right scientific theories eventually come out stronger whereas the weaker ones become extinct, which sounds like evolution, doesn&#8217;t it? Arguments like those of Behe or the ones about how specific biological structures could not come as a result of gradual change (see for instance the <a href="http://wiki.cotch.net/index.php/Evolution_of_flagella">evolution of flagella</a>), seem to stimulate many scientists to come (as they have done rather successfully so far) with convincing evolutionary trajectories that explain the emergence of these structures. This only makes the case for evolution stronger,</p>


	<p>In the case of cancer there seems to be enough evidence that tumour cells in tumours at an advanced stage of development differ significant from the cells in the tissue and the genetic difference allows them to outcompete healthy cells. This should make it difficult to argue against the fact that genetic mutations and natural selection lead to increasing complexity and adaptation.</p>]]>
      </description>
      <pubDate>Thu, 21 Feb 2008 12:36:43 -0000</pubDate>
      <link>http://network.nature.com/blogs/user/basanta/2008/02/20/about-evolution-the-theory</link>
      <guid>http://network.nature.com/blogs/user/basanta/2008/02/20/about-evolution-the-theory</guid>
      <dc:creator>David Basanta</dc:creator>
    </item>
    <item>
      <title>Far but not too far</title>
      <description>
        <![CDATA[<p><img src="http://viking.mech.kcl.ac.uk:51515/~david/me.jpeg" alt="" /> It has been a while since I last posted anything here. Part of the reason is that since I arrived to Dundee i haven&#8217;t had access to my print issues of Science and haven&#8217;t had the time to read Nature and other journals online. Still, this morning I was browsing an issue of the Economist in which they <a href="http://www.economist.com/science/displaystory.cfm?story_id=10640683">mention</a> this <a href="http://www.sciencemag.org/cgi/content/abstract/319/5864/813">article</a> in this week&#8217;s edition of Science.</p>


	<p>This research tries to answer the question of why is it that in richer (wealthier) human societies, families have on average fewer children. Although people have put other reasons, based mostly on sociology, the explanation these researchers favour is based on genetics. In general, and from the evolutionary point of view, it is a good thing for an individual not inbreed. Having to many genes in common with your partner means that the offspring will inherit virtually the same copy of all your genes, be them good or bad. Looking farther afield for your partner would likely result in offspring with a more diverse set of genes which means that at least a subset of your children have a good chance of having a rather good genetic mix.</p>


	<p>Wealthier societies tend to be also technologically more sophisticated and people are more likely to meet (and mate) with individuals who live farther away and whom which they share a smaller number of genes. Now, some diversity in the gene pool is a good thing but too much of it can be too much of a good thing. As the parents share a smaller share of the same variants of the same genes the number of genetic incompatibilities increase and the fertility rate decreases.</p>


	<p>The conclusion? if your goal in life is to maximise the potential success of your genes to live on in future generations then you might do good to consider distant cousins when planning your family.</p>]]>
      </description>
      <pubDate>Sat, 09 Feb 2008 23:26:06 -0000</pubDate>
      <link>http://network.nature.com/blogs/user/basanta/2008/02/09/far-but-not-too-far</link>
      <guid>http://network.nature.com/blogs/user/basanta/2008/02/09/far-but-not-too-far</guid>
      <dc:creator>David Basanta</dc:creator>
    </item>
    <item>
      <title>The Ransom game</title>
      <description>
        <![CDATA[<p><img src="http://viking.mech.kcl.ac.uk:51515/~david/me.jpeg" alt="" /> One of the things of being back to the UK is that, once in a while (but hopefully not too often) I can watch TV.</p>


	<p>Tonight one of the channels was offering Ransom, the Hollywood movie with Mel Gibson and Rene Russo in which the son of a millionaire is kidnapped for a ransom (2 million dollars). If you had to think of it in terms of game theory, then the payoff table could be something like this (pity that Nature Network does not make it easy to create tables in the posts):</p>


	<table>
		<tr>
			<td><strong>  </td>
			<td>R      </td>
			<td>K </td>
		</tr>
		<tr>
			<td>P  </td>
			<td> (3,3) </td>
			<td> (0,4) </td>
		</tr>
		<tr>
			<td>NP </td>
			<td> (4,0) </td>
			<td> (1,1)</td>
		</tr>
	</table>




	<p>Where rows represent the parents of the kidnapped kid and the columns represent the payoffs of the kidnapper. It basically means that the best outcome for the parents is to have the kid released without having to pay whereas the best outcome for the kidnapper is to be paid and still kill the kid (since the kid, once released, could become valuable help for the police to catch the kidnapper).</p>


	<p>This is a sequential game in which the kidnapper decides his strategy </strong>after<strong> the parents chose theirs. That means that the kidnapper maximises his payoff by killing the  kid regardless of what the parents decide to do. Knowing that, the only rational (within the rules of this game) strategy of the parents is not to pay. This is similar to the well known <a href="http://en.wikipedia.org/wiki/Prisoner's_dilemma">prisoners dilemma</a></p>


	<p>Clearly these dynamics do not favour the parents (nor it does the kidnapper) so in the movie Mel Gibson takes the following decision: he will not pay the money to the kidnapper but to anyone that would capture, dead or alive, the kidnapper. If the kidnapper releases the kid then he can walk away unharmed. These changes the game significantly because the strategy of the parents is already decided and seemingly cast in stone. Still, the table could look like this:</p>


	<table>
		<tr>
			<td></strong>  </td>
			<td>R     </td>
			<td>K </td>
		</tr>
		<tr>
			<td> <span class="caps">P  </span></td>
			<td> (3,3) </td>
			<td> (0,4) </td>
		</tr>
		<tr>
			<td> <span class="caps">NP </span></td>
			<td> (4,0) </td>
			<td> (0,-5) </td>
		</tr>
	</table>




	<p>In this case, the parents paying would mean that they pay to the kidnapper which we already mention that is an option that has been ruled out. If they don&#8217;t pay to the kidnapper they pay to a bounty hunter and we can assume that with a bounty of 2 million dollars, someone will eventually catch and maybe kill the kidnapper (which we represent here as -5 in terms of payoff). If we restrict ourselves to the row in which the parents pay a bounty hunter if the kidnapper does not release the kid by his own means then the rational option for the kidnapper is clearly to release the kid.</p>


	<p>Not such a great movie but they writers did really use game theory in a clever and interesting way.</p>]]>
      </description>
      <pubDate>Sun, 20 Jan 2008 23:44:55 -0000</pubDate>
      <link>http://network.nature.com/blogs/user/basanta/2008/01/20/the-ransom-game</link>
      <guid>http://network.nature.com/blogs/user/basanta/2008/01/20/the-ransom-game</guid>
      <dc:creator>David Basanta</dc:creator>
    </item>
    <item>
      <title>Facts about prostate cancer</title>
      <description>
        <![CDATA[<p><img src="http://viking.mech.kcl.ac.uk:51515/~david/me.jpeg" alt="" /> First post in 2008 and also the first since I moved to Dundee.</p>


	<p>These days I am trying to familiarise myself with prostate cancer and the effect of <span class="caps">TGF</span>-Beta on tumour progression. Some relevant information:</p>


	<p>The prostate is a gland of the mammalian reproductive system that stores and  produces an alkaline fluid (that makes 10-30% of the seminal fluid). Due to this acidity there is a lot of self renewal in the prostate. The following figure from wikipedia illustrates the different parts of a human prostate:</p>


	<p><img src="http://upload.wikimedia.org/wikipedia/commons/2/2f/Illu_prostate_zones.jpg" alt="" /></p>


	<p>The most important parts of prostate are the peripheral zone (biggest and responsible for 70% of the prostate cancers), the central zone (25% of tumours), the transition zone and the anterior fibro-muscular zone that contains stroma and is responsible for about 5% of the cancers.</p>


	<p>Prostate cancer normally starts in the peripheral zone and might be confined to the gland or spread to the surrounding tissue (stroma).</p>


	<p><img src="http://upload.wikimedia.org/wikipedia/en/thumb/0/0f/Prostatehistopath.jpg/500px-Prostatehistopath.jpg" alt="" /></p>


	<p>Probably the most relevant cells to study tumour initation and progression are the epithelial cells and the stromal cells. <strong>Epithelial</strong> cells are normally found in the surfaces of the structures of the body. Based on the results of the biopsy it is possible to estimate the  Gleason score with grades 1 to 5. <span class="caps">A GS</span> of grade 1 meaning a less aggressive tumour and 5 being a very aggressive tumour. The <strong>two</strong> most common patterns in the sample are graded this way and the two values combined into 1 in the range 2 to 10. This GS is a powerful predictor of a patient prognosis. A patient whose biopsy has a GS of value  6 or less has a 90% of chances of surviving more than 5 years whereas another one with a GS of 7 would have 50% or less.</p>


	<p><img src="http://upload.wikimedia.org/wikipedia/en/9/90/Gleasonscore2.jpg" alt="" /></p>


	<p>Now&#8230;tumour cells are not the whole story here, the microenvironment, or a bit more specifically, the <strong>stroma</strong>, does play a role. The stroma is made of connective cells in a tissue such as <strong>fibroblasts</strong>, <strong>smooth muscle</strong> cells and from <strong>extracellular matrix</strong> (produced by the fibroblasts) and several types of <strong>growth factors</strong> such as <strong>TGF-Beta</strong>.</p>


<span class="caps">TGF</span>-Beta is normally expressed at low levels in the <strong>base membrane</strong> (surrounding the prostate glands) and promote homeostasis by acting on hundreds of genes through <strong>SMAD-class</strong> proteins. The way that they help homeostasis is  by:
	<ol>
	<li>Epithelial inhibition.</li>
		<li>Recruiting mobile stroma.</li>
		<li>Myofibroblast induction (cells in between a fibroblast and a smooth muscle cell in differentiation).</li>
	</ol>


	<p><span class="caps">TGF</span>-Beta also seems to play a role in tumour progression and increased <span class="caps">TGF</span>-Beta expression is found in prostate cancers. Some questions still not answered and that could be addressed with a theoretical model are</p>


	<ol>
	<li>how would loss of <span class="caps">TGF</span>-Beta sensitivity affect tumour progression</li>
		<li>how would an increase in <span class="caps">TGF</span>-Beta expression affect tumour progression?</li>
		<li>what is the influence of this reactive stroma?</li>
	</ol>]]>
      </description>
      <pubDate>Tue, 15 Jan 2008 22:31:05 -0000</pubDate>
      <link>http://network.nature.com/blogs/user/basanta/2008/01/14/facts-about-prostate-cancer</link>
      <guid>http://network.nature.com/blogs/user/basanta/2008/01/14/facts-about-prostate-cancer</guid>
      <dc:creator>David Basanta</dc:creator>
    </item>
    <item>
      <title>Opencourseware and the future of teaching</title>
      <description>
        <![CDATA[<p><img src="http://viking.mech.kcl.ac.uk:51515/~david/me.jpeg" alt="" /> I was browsing a while ago the New York Times and found this <a href="http://www.nytimes.com/2007/12/19/education/19physics.html?em&#38;ex=1198386000&#38;en=68d841c3e65ac43a&#38;ei=5087%0A">article</a> about a 71 years old physics professor from <span class="caps">MIT</span> who became a web celebrity due to the <a href="http://ocw.mit.edu">MIT Opencourseware</a> initiative.</p>


	<p>What caught my interest were the comments of some of the subscribers who emailed him. These comments, all very positive, were about how <strong>inspiring</strong> they found the lectures and what a positive opinion they have acquired on <span class="caps">MIT</span> as a consequence of it. This programme is no longer limited to <span class="caps">MIT</span> and recently Yale started offering something similar.</p>


	<p>With a few years delay over the rest of the world I managed to find myself thrilled at the opportunities this represents for university teaching. Most of us who live to do research but once in a while (or way to often, depending on the situation) have to teach find very little motivation to do so. It is not very valuable from the career point of view and in many cases we don&#8217;t get many or motivated students. But if your lecture is in OpenCourseware (or a similar system) there is a good chance that we might be just a bit more careful when preparing the lectures. Not only that, but knowing that many people from around the world (some of them experts in the field, some of them potential collaborators, some of them future students) could be watching and that these people will tend to be highly motivated people then things start to change. Add to that the fact Universities like <span class="caps">MIT</span> are likely to find out that this system is not only a moral duty but also a very effective way to promote the University and its reputation (see all these <em>I love <span class="caps">MIT</span></em> in the article_). This should encourage universities to pay more attention (and money) to people that can be popular lecturers and thus able to raise the visibility of the university and bring in more students (since these eStudents might become fee paying students later on). I think we might be seeing the <strong>reinvention</strong> of teaching in Niversities.</p>]]>
      </description>
      <pubDate>Fri, 21 Dec 2007 15:46:51 -0000</pubDate>
      <link>http://network.nature.com/blogs/user/basanta/2007/12/21/opencourseware-and-the-future-of-teaching</link>
      <guid>http://network.nature.com/blogs/user/basanta/2007/12/21/opencourseware-and-the-future-of-teaching</guid>
      <dc:creator>David Basanta</dc:creator>
    </item>
    <item>
      <title>Mobility and the rock-paper-sicssors game</title>
      <description>
        <![CDATA[<p><img src="http://viking.mech.kcl.ac.uk:51515/~david/me.jpeg" alt="" /> This is (almost certainly) my last post about game theory research in 2007. Collecting information for my lecture on the topic this afternoon I found and read an <a href="http://www.nature.com/nature/journal/v448/n7157/full/nature06095.html">article</a> (relatively) recently published in Nature by Reichenbach, Mobilias and Frey (Ludwig Maximilians Universität München).</p>


	<p>The authors take a very well known game <strong>rock-paper-scissors</strong>, widely known in <a href="http://en.wikipedia.org/wiki/Rock,_Paper,_Scissors">game theory</a>. Now, imagine that you place the players in a space that is divided in a way similar to a chess board. Imagine that the players play with their immediate neighbours and that the collected points can be used to determine which players are removed from the board and which ones are allowed to stay and even colonise recently emptied places. In this situation and given that no strategy dominates the other two you should expect a constant shuffle of strategies. If you give each strategy a colour then you could imagine patterns of colours moving in different directions, never settling in a permanent position.</p>


	<p>Things seem to change if you allow an addition to a game. Once in a while we could allow two players to switch positions or a player to take an unoccupied slot and giving his old place up. According to these research, the more you allow this to happen (about a certain threshold the effects are more dramatic) the more that this coexistence of three different strategies becomes impossible. Thus motility could have a huge impact in the conservation of biodiversity. This is an interesting result and one is left just wishing that the had explained not only what happened but also (if even tentatively and with due care) why does it happen that way.</p>


	<p>Although the work is, for the time being, computational, the authors describe how research done with E.coli in petri dishes could be used to validate experimentally their conclusions.</p>]]>
      </description>
      <pubDate>Tue, 18 Dec 2007 11:08:10 -0000</pubDate>
      <link>http://network.nature.com/blogs/user/basanta/2007/12/18/mobility-and-the-rock-paper-sicssors-game</link>
      <guid>http://network.nature.com/blogs/user/basanta/2007/12/18/mobility-and-the-rock-paper-sicssors-game</guid>
      <dc:creator>David Basanta</dc:creator>
    </item>
    <item>
      <title>Rate of evolution in human history</title>
      <description>
        <![CDATA[<p><img src="http://viking.mech.kcl.ac.uk:51515/~david/me.jpeg" alt="" /> Recently the New York Times has <a href="http://www.nytimes.com/2007/12/11/science/11gene.html?_r=2&#38;ref=science&#38;oref=slogin&#38;oref=slogin">echoed</a> research by Robert Moyzis (UC Irvine) and Henry Harpending (Utah) recently published in <span class="caps">PNAS</span>. This research claims that human evolution was, contrary to what it was previously thought, especially active between 50000 and 10000 years ago. These results are still quite controversial but (quoting from the <span class="caps">NYT</span>) Dr. Moyzis comes with a couple of reasons:</p>


	<p>1) Human population started to grow in Africa and then elsewhere. Larger population size lead to more room for evolution to experiment with mutations</p>


	<p>2) As a result of population expansion, some of this early humans migrated to different parts of the world where they had to confront different environments (climates, diseases&#8230;) to which they had to adapt differently.</p>


	<p>This is interesting, plausible (which does not make it necessarily right) and also applicable to tumours. As tumours grow, the swell in the number of tumour cells make it very likely for mutations to increase the diversity of the population. Furthermore, the raise in population numbers and the space they take makes it also likely that subpopulations of the tumour will be subject to different microenvironments which should lead to different selection pressures. This would mean more diversity and and increased selection of phenotypic capabilities present at a given time in the tumour.</p>]]>
      </description>
      <pubDate>Sun, 16 Dec 2007 11:07:22 -0000</pubDate>
      <link>http://network.nature.com/blogs/user/basanta/2007/12/16/rate-of-evolution-in-human-history</link>
      <guid>http://network.nature.com/blogs/user/basanta/2007/12/16/rate-of-evolution-in-human-history</guid>
      <dc:creator>David Basanta</dc:creator>
    </item>
    <item>
      <title>The coevolution of parochial altruism and war</title>
      <description>
        <![CDATA[<p><img src="http://viking.mech.kcl.ac.uk:51515/~david/me.jpeg" alt="" /> I know I am, as of lately, reviewing articles and topics that skew more on game theory than on cancer. This is probably due to some lectures I am giving on that topic here in Dresden but lately it seems that both Nature and Science are paying more attention to this field.</p>


	<p>Jung-Kyoo Choi and Samuel Bowles. <strong>The coevolution of parochial altruism and war</strong>. <a href="http://www.sciencemag.org/cgi/content/abstract/318/5850/636">Science, Vol. 318, Oct. 2007</a></p>


	<p>The evolution of cooperation is a topic that has been discussed before in this blog but the authors of these paper consider an additional twist which is not only altruism but parochial altruism. Altruism means that we help other people and parochial altruism would stand for altruism towards our own group and agressivity towards other groups.</p>


	<p>Both traits on their own are difficult to explain in the sense that both are detrimental to the fitness of an individual displaying them. In order to study how it could evolve the authors designed and implemented a relatively sophisticated simulation environment in which individuals can be either parochial, altruistic, both or none. The results seem to imply that group evolution would explain that groups that favour the emergence of parochial altruists would have a selective advantage. These parochial altruists are willing to sacrifice themselves for the good of the community and in the simulations that sacrifice would come in terms of fighting with other groups. The groups with more fighters tend to decimate their competitors. Also, parochial altruists that are successful in these combats have a higher chance of producing offspring than the non parochial altruists of their community.</p>


	<p>A <a href="http://en.wikipedia.org/wiki/Public_goods_game">public good</a> game  is used to determine how the spoils of war are distributed. You could understand parochial altruists as cooperators that pool in the general good even when they know. Whereas in a normal game cooperators would have a difficult time, in this game, when the presence of hostile  is important, cooperators can prosper.</p>]]>
      </description>
      <pubDate>Fri, 14 Dec 2007 19:05:17 -0000</pubDate>
      <link>http://network.nature.com/blogs/user/basanta/2007/12/14/the-coevolution-of-parochial-altruism-and-war</link>
      <guid>http://network.nature.com/blogs/user/basanta/2007/12/14/the-coevolution-of-parochial-altruism-and-war</guid>
      <dc:creator>David Basanta</dc:creator>
    </item>
    <item>
      <title>Nowak: Five rules for the evolution of cooperation</title>
      <description>
        <![CDATA[<p><img src="http://viking.mech.kcl.ac.uk:51515/~david/me.jpeg" alt="" /> Martin Nowak. <strong>Five rules for the evolution of cooperation</strong>. <a href="http://tinyurl.com/6r8jrp">Science, Vol 314, pp 1560, December 2006</a> .</p>


	<p>I am discussing with some people in Dundee and Vanderbilt about how to study cancer progression in terms of evolution of cooperation (as hinted by <a href="http://cancerevo.blogspot.com/2007/02/axelrod-et-al-evolution-of-cooperation.html">Axelrod et al.</a>). One of the leading researchers in the field of biomathematics and game theory is Harvard&#8217;s Martin Nowak, In this paper he discusses five potential mechanisms of cooperation that could appear through Darwinian evolution.</p>


	<p><strong>Kin selection</strong> refers to the cooperation between individuals that are genetically related. It is easy to see how an individual will sacrifice something in order to help another individual as long as the relationship between what is sacrificed and the level of relatedness crosses a given threshold.</p>


	<p><strong>Direct reciprocity</strong> is also quite clear: if from our mutual cooperation we both get something more than what we put then it is viable. To explain its emergence Axelrod performed an study a couple of decades ago in which he found that of all competing strategies, the most successful one was <strong>Tit for tat</strong>. A player following this strategy will cooperate unless the other player does not. If the non cooperating player starts cooperating at some point then tit for tat will resume cooperation. In circumstances in which a level of noise might affect the perception of cooperation (if, for instance, one player thinks that the other one is not willing to cooperate when in fact he or she is) then a better strategy would be <strong>win-stay, lose-shift</strong> in which the player will keep a strategy for as long as it reports a benefit and will switch to the alternative one (be it cooperate or not) otherwise.</p>


	<p><strong>Indirect reciprocity</strong> on the other hand is less clear and is based on the idea of <strong>reputation</strong>. If individuals with a reputation for cooperation can be perceived by other participants and these participants are more likely to cooperative with individuals with a good reputation then cooperation could evolve even when the individuals in the population do not interact repeatedly. Problem with indirect reciprocity is that, depending on reputation requires skills normally not found in animals outside our own species.</p>


	<p><strong>Network reciprocity</strong> falls in the easily understandable category. Most game theoretical studies assume a well mixed population. That is not realistic and spatial models (like those based on Cellular Automata) and graph models (known as network models among physicists) make it easier to study cooperation when the individuals are more likely to interact with a subset of the population. It is known that in many cases, cooperation is more likely to emerge in spatial than in non spatial models. From the mathematical point of view though, these systems are easy to simulate in a computer than to analyse formally.</p>


	<p><strong>Group selection</strong> is a controversial type of selection in which selection does work not only at the level of the individuals but also at the level of the species to which these individuals belong. According to this line of thought although cooperation might not benefit cooperative individuals (whose efforts could be misused by freeriders), species in which cooperation emerges are more likely to stick around that species with exclusively selfish behaviour.</p>]]>
      </description>
      <pubDate>Sun, 09 Dec 2007 17:21:18 -0000</pubDate>
      <link>http://network.nature.com/blogs/user/basanta/2007/12/09/nowak-five-rules-for-the-evolution-of-cooperation</link>
      <guid>http://network.nature.com/blogs/user/basanta/2007/12/09/nowak-five-rules-for-the-evolution-of-cooperation</guid>
      <dc:creator>David Basanta</dc:creator>
    </item>
    <item>
      <title>Jensen et al:  Chimpanzees are rational maximizers in an Ultimatum game</title>
      <description>
        <![CDATA[<p><img src="http://viking.mech.kcl.ac.uk:51515/~david/me.jpeg" alt="" /> Keith Jensen, Josep Call and Michael Tomasello. <strong>Chimpanzees Are Rational Maximizers in an Ultimatum Game</strong>. <a href="http://www.sciencemag.org/cgi/content/full/318/5847/107">Science 5 October 2007:Vol. 318. no. 5847, pp. 107 &#8211; 109</a>.</p>


	<p>I am always playing catch up with my issues of Nature and Science and this is no exception. One of the main frustrations of game theoreticians in sociology is that humans do not behave like rational players. Ironically enough that does not seem to be a problem for those of us that use game theory in biology. In nature individuals of a species seek to maximise their benefit (otherwise they become extinct).</p>


	<p>In their paper Jensen and coauthors show how chimpanzees,our closest relatives, do play like rational players in the <a href="http://en.wikipedia.org/wiki/Ultimatum_game">ultimatum game</a>. In the Ultimatum game one of the players offers how to split a particular item and then the other players decides whether to accept or reject the offer. If the offer is rejected then none of the players gets anything. Humans tend to reject what they perceive as <em>unfair</em> deals (like 20-80 or more skewed) and seldom offer deals more skewed than 60-40. Chimpanzees on the other hand where likely to offer unfair deals and when offered, they were likely to accept them.</p>]]>
      </description>
      <pubDate>Fri, 30 Nov 2007 12:57:52 -0000</pubDate>
      <link>http://network.nature.com/blogs/user/basanta/2007/11/30/jensen-et-al-chimpanzees-are-rational-maximizers-in-an-ultimatum-game</link>
      <guid>http://network.nature.com/blogs/user/basanta/2007/11/30/jensen-et-al-chimpanzees-are-rational-maximizers-in-an-ultimatum-game</guid>
      <dc:creator>David Basanta</dc:creator>
    </item>
    <item>
      <title>Again with science in Germany</title>
      <description>
        <![CDATA[<p><img src="http://viking.mech.kcl.ac.uk:51515/~david/me.jpeg" alt="" /> I wrote quite <a href="http://network.nature.com/blogs/user/basanta/2007/10/16/science-in-germany">recently</a> about the special issue of Science about research in Germany. This time Nature has found space to write <a href="http://www.nature.com/naturejobs/2007/071115/full/nj7168-452a.html">this</a> about the current direction of German universities.</p>


	<p>The article takes advantage of the recent (Nobel) successes of German science to comment on the new governmental approach to science funding in which the universities are not treated equally. Winners of the second round of the excellence initiative: the technical university of Aachen, the universities of Freiburg, Heidelberg, Göttingen and Kostanz and the Free University of Berlin join the winners of the first round: the technical universities of Munich and Karlsruhe and the Ludwig Maximiliam University of Munich. Then the writer goes on to focus on all the positive things that will come from this new approach (like a perceived increase in the capability to compete with American universities) but also mentions the things that are not likely to change: that the majority of the PhD students and postdocs in Germany are unlikely to ever get a non-temporal position.</p>


	<p>It is also worth noting that asides to some mention to an advertisement of <a href="http://www.nature.com/uidfinder/10.1038/nj6936-204a">Dresden</a> there is no much mention to the fact that no former <span class="caps">GDR</span> university has managed to achieve the status of elite university despite hopes of Humboldt University of Berlin, Leipzig or Dresden.</p>]]>
      </description>
      <pubDate>Sun, 25 Nov 2007 16:52:56 -0000</pubDate>
      <link>http://network.nature.com/blogs/user/basanta/2007/11/25/again-with-science-in-germany</link>
      <guid>http://network.nature.com/blogs/user/basanta/2007/11/25/again-with-science-in-germany</guid>
      <dc:creator>David Basanta</dc:creator>
    </item>
    <item>
      <title>Group selection</title>
      <description>
        <![CDATA[<p><img src="http://viking.mech.kcl.ac.uk:51515/~david/me.jpeg" alt="" /> Via a friend in Vanderbilt (Hi Simon!) I got access to a <a href="http://www.newscientist.com/channel/being-human/mg19626281.500-evolution-survival-of-the-selfless.html">recent article in New Scientist</a> about multi-level evolution and group selection.</p>


	<p>It is something of <em>The rise, fall and rise of group selection</em>. It basically goes through the many reasons by which group selection was dismissed in the 60s and how, nowadays, people start to accept that it might be more relevant than previously thought. It is interesting that the article draws from so many theoretical models (many of them based on game theory) to show how they anticipated the experimental results that were found later. According to some (quite popular) interpretation of Dawkins selfish gene, only the most strictly selfish behaviour has a chance of spreading through a population. The experiment described in the article in which <strong>prudent</strong> virus strains could outcompete the nastier ones proves that this does not necessarily have to be the case. In general it is clear the pro &#8216;multiple levels of selection&#8217; bias in the article.</p>


	<p>My take is that Dawkins is right that anything that is detrimental to the goal of a gene to perpetuate will have slim chances of surviving in an evolutionary process. Still cooperation is known to exist and species capable of cooperation are, in many cases, more likely to thrive than those that are not. The twist lays on the fact that cooperation does not need to be detrimental for a gene (although not necessarily for the individual that carries it). First, species in which selfishness precludes collaboration and promotes explotation, selfish genes might die due to their own success. There is one typical game in game theory called the tragedy of the commons which explains how a common good can be overexploited by uncollaborative individuals with the result of everyone in the population paying a steep price for it (potentially extintion). It is also known that collaborative behaviour can emerge in a population if it benefits other individuals with related genes (kin selection), the participating individuals (the Hawk-Dove game could be used to explain that one) or if collaborative individuals manage to establish a punishment mechanism (there was a talk in Dresden by Karl Sigmund just about a month ago in which he explained this).</p>]]>
      </description>
      <pubDate>Mon, 19 Nov 2007 11:13:19 -0000</pubDate>
      <link>http://network.nature.com/blogs/user/basanta/2007/11/19/group-selection</link>
      <guid>http://network.nature.com/blogs/user/basanta/2007/11/19/group-selection</guid>
      <dc:creator>David Basanta</dc:creator>
    </item>
    <item>
      <title>A non specialist view on systems biology</title>
      <description>
        <![CDATA[<p><img src="http://viking.mech.kcl.ac.uk:51515/~david/me.jpeg" alt="" /> No much time for postings since my group will go on their annual retreat to the mountains of <a href="http://picasaweb.google.com/dbasanta/SChsischeSchweiz">Sächsische Schweiz</a>. With some luck I should be able to tell the group about how a spatial method of game theory could be used to study some aspects of tumour invasion (see <a href="http://cancerevo.blogspot.com/2006/12/gatenby-and-smallbone-glycolysis-and.html">this old entry</a>).<br /><img src="http://lh6.google.com/dbasanta/R0A4AHEhCSI/AAAAAAAACd8/U-01ms31uW0/DSC03019.JPG?imgmax=512" alt="" /><br />In any case, the topic today is systems biology. I normally take a look at the non scientific press to see what science is reported and how is it reported. A couple of weeks ago, The Economist <a href="http://economist.com/science/displaystory.cfm?story_id=10018596">reported</a> about Systems biology in an interesting article. Systems biology is for me one of these concepts that is difficult to describe accurately but easy to say <em>Yeah, I know what you mean with that</em> when someone tries to describe it. The description in the article is not going to change all that but the examples (like that of Denis Noble at Oxford) are interesting and described in an engaging way</p>]]>
      </description>
      <pubDate>Tue, 13 Nov 2007 18:37:52 -0000</pubDate>
      <link>http://network.nature.com/blogs/user/basanta/2007/11/13/a-non-specialist-view-on-systems-biology</link>
      <guid>http://network.nature.com/blogs/user/basanta/2007/11/13/a-non-specialist-view-on-systems-biology</guid>
      <dc:creator>David Basanta</dc:creator>
    </item>
    <item>
      <title>Guardian UK Universities research ranking</title>
      <description>
        <![CDATA[<p><img src="http://viking.mech.kcl.ac.uk:51515/~david/me.jpeg" alt="" /> University rankings are probably like statistics in baseball: they are fun as long as you don&#8217;t take them seriously. I am not a fan of of baseball myself (if I had to pick a sport then it would probably be what most of the world refers as football). In any case I have read enough essays from Stephen J. Gould to see how a baseball fan could find statistics fun. Better performing teams tend to have better numbers in those statistics but if the coach decided to focus on improving those numbers (and just the numbers alone) it is likely that the results would be disastrous.</p>


	<p>So for the sake of light-hearted fun I will post here a <a href="http://education.guardian.co.uk/higher/specialreport/tables/0,,2201298,00.html">ranking of research in British universities</a> that the Guardian has compiled on occasion of the impeding deadline for submissions to the Research Assessment Exercise that will determine how a lot of the government research money will be distributed.</p>


	<p>On top, the usual ones: Oxford, Cambridge, Imperial, <span class="caps">UCL</span>, Edinburgh, King&#8217;s, Birmingham, Manchester, Glasgow and Bristol. It looks likely that, as usual Oxford, Cambridge and London will get the bulk of the money. Scottish Universities do not to bad either with Edinburgh in the 5th position, Glasgow on the 9th and Dundee still in the top 20.</p>


	<p>Now, in order to compile this statistics, the Guardian measures the usual which, of course, includes publication numbers and impact. Another blogger in Nature Networks and a fellow Dresdner, Joseph Zhou, has <a href="http://network.nature.com/blogs/user/sunon77/2007/10/29/the-story-behind-the-proof-of-fermats-last-theorem">posted this</a> about how Andrew Wiles found the time to proof <a href="http://en.wikipedia.org/wiki/Fermat's_last_theorem">Fermat&#8217;s last theorem</a> : He just wrote 20 papers, kept them on this desk and submitted them at a rate of two a year in order to keep his academic career going while using his time in the very risky task of finding a solution to a problem that had been unsolved for hundreds of years.</p>


	<p><span class="caps">UPDATE</span>: Ranking from the <a href="http://education.guardian.co.uk/higher/news/story/0,,2207256,00.html">THES</a>. Still same story.</p>]]>
      </description>
      <pubDate>Tue, 30 Oct 2007 10:50:18 -0000</pubDate>
      <link>http://network.nature.com/blogs/user/basanta/2007/10/30/guardian-uk-universities-research-ranking</link>
      <guid>http://network.nature.com/blogs/user/basanta/2007/10/30/guardian-uk-universities-research-ranking</guid>
      <dc:creator>David Basanta</dc:creator>
    </item>
    <item>
      <title>Using mathematics to tackle cancer: book review in Nature</title>
      <description>
        <![CDATA[<p><img src="http://viking.mech.kcl.ac.uk:51515/~david/me.jpeg" alt="" /> A friend of mine (hi Peter!) has told me about the <a href="http://www.nature.com/nature/journal/v449/n7165/full/449978a.html">book review</a> in the latest issue of Nature. The review is by no less than Robert Weinberg, one of grandees of cancer research and the book is entitled <em>Dynamics of Cancer: Incidence, Inheritance, and Evolution</em> by <a href="http://ecoevo.bio.uci.edu/">Steven A. Frank</a>, at the department of ecology and evolution at the University of California, Irvine.</p>


	<p>Unfortunately, the review itself does not say that much about the book so I might have to wait until I get hold of a copy before I can tell if it would be a good idea to buy it or not. It is clear thought that Weinberg sees it as a revival of the mathematical biology school that started in the University of Chicago in the 60s. If he thinks that mathematical biology is of any use in cancer research or not does not come very clear in his review and one suspects that he is quite skeptical about its future role.</p>]]>
      </description>
      <pubDate>Mon, 29 Oct 2007 18:06:24 -0000</pubDate>
      <link>http://network.nature.com/blogs/user/basanta/2007/10/29/using-mathematics-to-tackle-cancer-book-review-in-nature</link>
      <guid>http://network.nature.com/blogs/user/basanta/2007/10/29/using-mathematics-to-tackle-cancer-book-review-in-nature</guid>
      <dc:creator>David Basanta</dc:creator>
    </item>
    <item>
      <title>Game Theory and economics</title>
      <description>
        <![CDATA[<p><img src="http://viking.mech.kcl.ac.uk:51515/~david/me.jpeg" alt="" /> If you had come to this blog because you typed &#8220;game theory blog&#8221; in google then this article will not come as a shock but for those of you who would expect to see something about either evolution or cancer or (preferably) both then this is not the usual post.</p>


	<p>Still, game theory has been making headlines the last couple of weeks and since this is one of my favourite mathematical tools I could not help coming with a post.</p>


	<p>Fist, The Economist had an <a href="http://economist.com/finance/displaystory.cfm?story_id=9867020">article</a> in which the especulate on how game theory could be used to save the world. One of the problems enforcing the measures needed to prevent climate change is that although most players (countries in this game) recognise to some extend that doing something about it is in everybody&#8217;s interest. But also, like in <em>the tragedy of the commons</em> game, players know that what is really in their interest is to let everybody else take the burden of protecting the environment while they keep carrying on as usual. The Economist cites research from an institute called New Energy Finance, but anyone working on game theory knows that one approach to the dilemma of the tragedy of the commons is to <strong>punish</strong> the free riders. Another complementary solution is to set targets that are less ambitious but that can be achieved quickly in order to have frequent and accurate feedback on what players are cooperating and which ones are not.</p>


	<p>It has been proven that game theory can help you be awarded a nobel prize, it would be nice if it could also be a tool to coerce countries into taking the measures needed to prevent <strong>climate change</strong> (or maybe other tasks that also benefit mankind but require the collaboration of many countries).</p>]]>
      </description>
      <pubDate>Mon, 22 Oct 2007 17:37:02 -0000</pubDate>
      <link>http://network.nature.com/blogs/user/basanta/2007/10/22/game-theory-and-economics</link>
      <guid>http://network.nature.com/blogs/user/basanta/2007/10/22/game-theory-and-economics</guid>
      <dc:creator>David Basanta</dc:creator>
    </item>
    <item>
      <title>Science in Germany</title>
      <description>
        <![CDATA[<p><img src="http://viking.mech.kcl.ac.uk:51515/~david/me.jpeg" alt="" /> Last week was a good week for German science. One of the two physics laureates and the only laureate in Chemistry are Germans who have developed their ideas in German universities and research institutes.</p>


	<p>This does not mean that German science should rest on their laurels, there are some issues that are holding back German universities and research institutes from reaching their full potential. Some of them are discussed <a href="http://sciencecareers.sciencemag.org/career_development/previous_issues/articles/2007_09_21/science_opms_r0700039/(parent)/">here</a>.<br />One feature of the German academic system is that there seems to be a two-layer system with the <strong>Max Planck Society</strong> carrying out most of the world-class research and the Universities taking responsability for the teaching. The other feature, shared by most continental European countries, is that there is a <strong>flat field</strong> in which universities are provided with funds according to the size of the student population (and the specific policies of the local state). This dependency from the Federal and state administration makes change more difficult. That coupled with a lack of incentives for Universities to produce outstanding research (since the state will finance them the same regardless) means that some good researchers move to the Max Plancks (or abroad) leaving the university system without some good researchers that could also teach.</p>


	<p>One issue not mentioned in the article though is the difficulty for young (or not so young) researchers to obtain more than temporal contracts. Whereas this seems to be a problem in most countries, in Germany this is better and worse. It is <strong>worse</strong> because there are not that many positions for a postdoc asides from becoming a full professor, leaving many of us without hope to have an academic career. It is also <strong>better</strong> because in Germany, people with a PhD are less likely to be discriminated for the fact of having a doctorate. In fact many companies are happy to hire PhDs for more  than their R&#38;D departments.</p>


	<p><span class="caps">UPDATE</span>: Just one interesting fact that I read today in the paper about the procedence of the nobel laureates from 1951 to 2006: 56% american, 13.2% British, 8.7% German, 3.38% Russian and 2.8% French</p>]]>
      </description>
      <pubDate>Tue, 16 Oct 2007 17:31:59 -0000</pubDate>
      <link>http://network.nature.com/blogs/user/basanta/2007/10/16/science-in-germany</link>
      <guid>http://network.nature.com/blogs/user/basanta/2007/10/16/science-in-germany</guid>
      <dc:creator>David Basanta</dc:creator>
    </item>
    <item>
      <title>The quality of health systems around the world</title>
      <description>
        <![CDATA[<p><img src="http://viking.mech.kcl.ac.uk:51515/~david/me.jpeg" alt="" /> It was news a few days ago. A think tank, the Health Consumer Powerhouse, released a ranking of the best health systems in Europe. The <a href="http://www.healthpowerhouse.com/archives/cat_media_room.html">ranking</a> is headed by <strong>Austria</strong> and followed by <strong>Netherlands, France, Switzerland, Germany, Sweden, Norway, Finland, Denmark and Belgium</strong>.</p>


	<p>This ranking is slightly different than the <a href="http://www.photius.com/rankings/healthranks.html">one provided by the World Health Organization</a> which includes non EU countries although most of the top positions are in Europe. In this ranking the top 10 countries are <strong>France, Italy, San Marino, Andorra, Malta, Singapore, Spain, Oman, Austria and Japan</strong>. UK comes at position 18th, Germany at position 25th and the US in position 37. The <span class="caps">WHO</span> ranking seems to be less biased towards Scandinavian countries and more biased to Mediterranean ones.</p>]]>
      </description>
      <pubDate>Wed, 10 Oct 2007 09:03:36 -0000</pubDate>
      <link>http://network.nature.com/blogs/user/basanta/2007/10/10/the-quality-of-health-systems-around-the-world</link>
      <guid>http://network.nature.com/blogs/user/basanta/2007/10/10/the-quality-of-health-systems-around-the-world</guid>
      <dc:creator>David Basanta</dc:creator>
    </item>
    <item>
      <title>ECCS workshop on evolution and game theory</title>
      <description>
        <![CDATA[<p><img src="http://viking.mech.kcl.ac.uk:51515/~david/me.jpeg" alt="" /> If there was something I was looking forward in the European Conference on Complex Systems it was today&#8217;s workshop on <a href="http://www.theo-physik.uni-kiel.de:81/~claussen/eccs07eg/">Evolution and game theory</a>.</p>


	<p>The workshop was organised by J. Claussen (Kiel), C. Hauert (Harvard) and G. Szabo (Budapest) and allowed me to to have an overview of recent research in game theory. Of course this view will be biased, first by the fact that not every game theoretician is interested in complex systems (and thus won&#8217;t attend a conference like this) and also because the organisers probably have their own preferences too. Thus, although my view until now is the GT is more popular among economists and evolutionary biologists, a good proportion of the speakers today were physicists.</p>


	<p>That may (or may not) have influenced much their topic of research. In general the talks focused on the classical games used to study the evolution of co-operation: prisoners dilemma and public goods game (I mentioned an introduction to these games in an <a href="http://cancerevo.blogspot.com/2007/03/old-dawkins-video-on-cooperation.html">old post</a>). With this games in mind people try all kinds of variations: spatial models, games with stochastic payoffs, stochastic strategies, games with more than two players interacting, games in which players interact via graphs (or networks). Although not much was shown in terms of applications it was quite helpful to listen about things I could use to improve my <a href="http://wwwpub.zih.tu-dresden.de/~basanta/abstract_cr07.pdf">glycolysis game</a>.</p>


	<p>The workshop also allowed me to introduce my model to some people like <a href="http://www.mimuw.edu.pl/~miekisz/">Jacek Miękisz</a> (Warsaw) so I got a few hints of what I could use in the next version.</p>]]>
      </description>
      <pubDate>Fri, 05 Oct 2007 16:53:02 -0000</pubDate>
      <link>http://network.nature.com/blogs/user/basanta/2007/10/05/eccs-workshop-on-evolution-and-game-theory</link>
      <guid>http://network.nature.com/blogs/user/basanta/2007/10/05/eccs-workshop-on-evolution-and-game-theory</guid>
      <dc:creator>David Basanta</dc:creator>
    </item>
    <item>
      <title>Stem cells and breast cancer</title>
      <description>
        <![CDATA[<p><img src="http://viking.mech.kcl.ac.uk:51515/~david/me.jpeg" alt="" /> Robert Weinberg and colleagues have just published an article in Nature (see <a href="http://www.nature.com/nature/journal/v449/n7162/edsumm/e071004-07.html">here</a> and <a href="http://www.nature.com/nature/journal/v449/n7162/full/nature06188.html">here</a>) where they study the role of a type of stem cells known as <strong>mesenchymal stem cells</strong> (MSCs) in promoting metastasis.</p>


	<p>It seems that MSCs that interact with weakly metastatic cells release a paracrine substance (CCL5) that promotes metastasis. The effect works for as long as the tumour cells have access to <strong>CCL5</strong> so these cells revert to their normal state once the factor is out of reach.</p>


	<p>Interestingly, Weinberg reckons that this mechanism is unlikely to be breast-specific and that it could be used to explain metastasis in many kinds of cancers. This work seems to give strength to the idea that dealing with stem cells is necessary when treating a cancer.</p>]]>
      </description>
      <pubDate>Thu, 04 Oct 2007 08:44:18 -0000</pubDate>
      <link>http://network.nature.com/blogs/user/basanta/2007/10/04/stem-cells-and-breast-cancer</link>
      <guid>http://network.nature.com/blogs/user/basanta/2007/10/04/stem-cells-and-breast-cancer</guid>
      <dc:creator>David Basanta</dc:creator>
    </item>
    <item>
      <title>Karl Sigmund's talk at ECCS</title>
      <description>
        <![CDATA[<p><img src="http://viking.mech.kcl.ac.uk:51515/~david/me.jpeg" alt="" /> This week, Dresden is hosting the European Conference in Complex Systems (<a href="http://trafficforum.de/dresden">ECCS&#8217;07</a>) which I am attending.</p>


	<p><img src="http://vwitme011.vkw.tu-dresden.de/TrafficForum/dresden/aXXECCS07_poster.jpg" alt="" /></p>


	<p>I was particularly interested in the keynote of <a href="http://homepage.univie.ac.at/Karl.Sigmund/">Karl Sigmund</a> at the University of Vienna, about the evolution of cooperation. As some of you know, the evolution of cooperation is something that is normally studied using game theory. GT can be used to explain the situations in which genetically related and (sometimes unrelated) individuals cooperate. Evolution of cooperation could potentially be used to explain how is it that tumour cells acquire all the capabilities required to progress to malignancy overcoming the anti cancer mechanisms of our bodies (already discussed <a href="http://cancerevo.blogspot.com/2007/02/axelrod-et-al-evolution-of-cooperation.html">here</a>).</p>


	<p>Since tumour cells are not necessarily so genetically related (at least compared to non tumour cells), the cooperation has meaning only when both cooperating cells receive a benefit. Without referring to cancer, Prof. Sigmund talked about the ways in which cooperation can emerge in populations in which individuals may chose to cooperate or not. Of those that chose to cooperate some of them might actually do so or alternatively can cheat, playing to be cooperators and receiving the benefits without actually contributing to the common good. In order to enforce cooperation, cooperating individuals might chose to punish defectors (thus making cheat more costly than cooperation) or non punishers. It is assumed that punishers do have to pay a bit (although not as much as the punished).This solution is not entirely satisfactory: in this way punishing enforces cooperation that benefits all cooperators, be it punishers or not, but with costs that are shouldered only by punishers. Thus punishing is a second level of cooperating that should need the same kind of reinforcement to work.</p>


	<p>Prof. Sigmund showed some simulations (that can be found in this <a href="http://www.univie.ac.at/virtuallabs/VolPun/">site</a>) in which the <br />dynamics change depending on how many types of players we put in the game. In games with only cooperators, punishers (also cooperators) and cheaters, the cheaters tend to take over the population. Interestingly enough when non cheating non cooperators (they just never benefit from other people&#8217;s work but they do not contribute either) are allowed then it is punishers who thrive.</p>


	<p>Interesting fact about this conference is that the keynotes and talks are being videorecorded and will be put online at Videolectures.net <a href="http://videolectures.net/">site</a>.</p>]]>
      </description>
      <pubDate>Tue, 02 Oct 2007 09:44:34 -0000</pubDate>
      <link>http://network.nature.com/blogs/user/basanta/2007/10/02/karl-sigmunds-talk-at-eccs</link>
      <guid>http://network.nature.com/blogs/user/basanta/2007/10/02/karl-sigmunds-talk-at-eccs</guid>
      <dc:creator>David Basanta</dc:creator>
    </item>
    <item>
      <title>Evolution in the individual</title>
      <description>
        <![CDATA[<p><img src="http://viking.mech.kcl.ac.uk:51515/~david/me.jpeg" alt="" /> Philip Ball has an interesting article in last week&#8217;s issue of Nature entitled <a href="http://www.nature.com/news/2007/070917/full/070917-11.html">Why a person does not evolve in one lifetime</a>.</p>


	<p>Of course he notes that evolution is really happening in our organism and at least in one case (the immune system) evolution happens to our advantage. The point is nonetheless, that our organism has been evolved to avoid evolving itself (with the mentioned exception), or at least, to make this somatic evolution as unlikely as possible. The way to do this is by means of stem cells and transient amplifying cells.</p>


	<p>This hypothesis was tested computationally by <a href="http://www.eebweb.arizona.edu/Faculty/Bios/pepper.html">John Pepper</a> and colleagues when working at the <a href="http://www.santafe.edu">Santa Fe Institute</a>. If every cell in the organism is in charge of making sure that there are enough cells of their own type then you don&#8217;t need many alterations to have cancer. The route is a bit more complicated. <strong>Stem cells</strong> are in charge of making sure that there are enough cells of a given type. They divide very slowly and have been evolved to be especially immune to mutations. They divide creating a copy of themselves and a <strong>transient amplifying cell</strong>. These TACs divide in a way that the offspring is different from the mother so even if they mutate, given that the offspring is different, it is unlikely that their faulty behaviour will be inherited and spread in a tissue.</p>


	<p>Based on these assumptions the computer models show that even though energetically wasteful, this system minimises significantly the possibility of cancer.</p>]]>
      </description>
      <pubDate>Thu, 27 Sep 2007 15:38:18 -0000</pubDate>
      <link>http://network.nature.com/blogs/user/basanta/2007/09/27/evolution-in-the-individual</link>
      <guid>http://network.nature.com/blogs/user/basanta/2007/09/27/evolution-in-the-individual</guid>
      <dc:creator>David Basanta</dc:creator>
    </item>
    <item>
      <title>Mercenary immune cells can fight your cancer</title>
      <description>
        <![CDATA[<p><img src="http://viking.mech.kcl.ac.uk:51515/~david/me.jpeg" alt="" /> Work in Lyon went quite well and asides from making sense of some data we welcomed a physician on board our project. Also I got to learn more about a project in which my collaborator in Lyon, Benjamin Ribba, is involved. I got to know about <span class="caps">ETOILE </span>(French for star), the project in which haedrontherapy will be used to treat some specific patients. This type of therapy works in a similar way to radiotherapy but can be controlled so it affects only the part of the tissue affected by the tumour. For reasons that I still ignore it is mainly used in very young or older patients and requires fairly sophisticated (as in expensive and big) installations.</p>


	<p>Also this week I found this piece of <a href="http://news.bbc.co.uk/2/hi/health/7003019.stm">news</a> reported at the <span class="caps">BBC</span>&#8217;s website about research by scientists at Wake Forest show how white blood cells (granulocytes) from one person can help treat a cancer in a different one.  Interestingly the article mentions that granulocytes (which according to <a href="http://en.wikipedia.org/wiki/Granulocyte">wikipedia</a> that refers in many cases to <strong>neutrophils</strong>) are not normally thought to be relevant in cancer research. That should support the research of people (Antonio Bru at <a href="http://www.ucm.es">UCM</a> comes to mind here) studying how the non adaptive part of the immune system (neutrophils) could be leveraged as a cancer therapy.</p>


	<p>A second interesting finding is that the granulocyte count in patients with cancer is lower than in healthy people and that even in that case this number changes in the year with higer counts in the spring/summer and lower in the autumn/winter. Could it be that (and I not claiming it is my idea, I heard it before) a tumour is more likely to start when the immune system is <strong>depressed</strong>?</p>


	<p>It is also interesting that this researchers found how (at least in mice) to transplant cancer-fighting granulocytes from one individual to another. Since different people have different immune systems that could imply that we could use our own diversity as a species to fight tumours, whose growth could be explained as cells taking advantage of somatic evolution</p>]]>
      </description>
      <pubDate>Fri, 21 Sep 2007 18:22:45 -0000</pubDate>
      <link>http://network.nature.com/blogs/user/basanta/2007/09/21/mercenary-immune-cells-can-fight-your-cancer</link>
      <guid>http://network.nature.com/blogs/user/basanta/2007/09/21/mercenary-immune-cells-can-fight-your-cancer</guid>
      <dc:creator>David Basanta</dc:creator>
    </item>
    <item>
      <title>Microenvironment and somatic evolution</title>
      <description>
        <![CDATA[<p><img src="http://viking.mech.kcl.ac.uk:51515/~david/me.jpeg" alt="" /> I have not posted anything in this blog for quite some time. Attending workshops (I had one in Dresden today) and visiting collaborators (I am off to Lyon tomorrow) leave very little precious time for blogging. Which is not to say that nothing is happening, quite the opposite.</p>


	<p>My trip tomorrow will allow me to meet Dr. Benjamin Ribba (Universite Claude Bernard) with whom I am investigating the role of the microenvironment in driving cancer evolution. We start from the hypothesis put forward by Hanahan and Weinberg 7 years ago that tumour cells have to acquire a number of capabilities if a group of rapidly and unorderly dividing cells is to become a cancer. The capabilities mentioned in their paper (<a href="http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&#38;Cmd=ShowDetailView&#38;TermToSearch=10647931&#38;ordinalpos=14&#38;itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum">Cell, 2000, Vol 100, 57-70</a>) are: unlimited replicative potential, self sufficiency of growth signals, ignoring anti growth signals, angiogenesis,evasion of apoptosis and invasiveness. Now, from the evolutionary view point, what makes a cell with a particular phenotype (resulting from acquiring one or more of these capabilities) more or less successful is its capability to produce offspring and this capability will depend on how this phenotype adapts and modifies the microenvironment it inhabits. Different microenvironments are likely to lead to cancers that become aggressive using different different paths (of capability acquisition). It might even be the case that we could find out which microenvironments are more likely to lead to cancers in which this path takes longer or does not occur in a relevant amount of time (that is, the normal life span of a human being).</p>]]>
      </description>
      <pubDate>Mon, 17 Sep 2007 17:02:03 -0000</pubDate>
      <link>http://network.nature.com/blogs/user/basanta/2007/09/17/microenvironment-and-somatic-evolution</link>
      <guid>http://network.nature.com/blogs/user/basanta/2007/09/17/microenvironment-and-somatic-evolution</guid>
      <dc:creator>David Basanta</dc:creator>
    </item>
    <item>
      <title>Summer school in Dundee</title>
      <description>
        <![CDATA[<p><img src="http://viking.mech.kcl.ac.uk:51515/~david/me.jpeg" alt="" /> I am back from the <a href="http://www.maths.dundee.ac.uk/summerschool">summer school</a> organised by members of the <span class="caps">EU </span>Network in Dundee, Scotland.</p>


	<p>As was the case last year, these summer schools consist of a mixture of lectures given by senior researchers about general topics of cancer modelling and short contributed talks given by the younger (and not so younger) researchers about our specific research.</p>


	<p>This year mean topic seemed to be radiotherapy. Radiotherapy works on the principle that tumour cells have a faulty <span class="caps">DNA</span> repair mechanism compared with healthy cells. Using radiation it is possible to produce breaks on the <span class="caps">DNA</span> which might incapacitate the cell. The trick is in how much and how often. Even if the right amount of radiation is used, too many doses might not allow healthy cells to repair the damage and thus destroy the tissue. Too few doses and then the therapy would be useless.</p>


	<p>Now, there are mathematical models (starting with the Linear Quadratic Model) that can predict, given some information about the tissue, what is the best radiation and dosage for a patient. Apart from mathematics we had the luck to have some physicians in the audience. Is always refreshing, coming from the theoretical side, to listen to their point of view. Is also shocking (but necessary if we theoreticians want to understand what is at stake) to see images of patients with breast cancer. Some times, watching our colourful simulations on the screen, it is too easy to forget that Cancer is a disease that kills many people, and not in a particularly painless way.</p>]]>
      </description>
      <pubDate>Tue, 04 Sep 2007 17:10:30 -0000</pubDate>
      <link>http://network.nature.com/blogs/user/basanta/2007/09/04/summer-school-in-dundee</link>
      <guid>http://network.nature.com/blogs/user/basanta/2007/09/04/summer-school-in-dundee</guid>
      <dc:creator>David Basanta</dc:creator>
    </item>
    <item>
      <title>Pandemics</title>
      <description>
        <![CDATA[<p><img src="http://viking.mech.kcl.ac.uk:51515/~david/me.jpeg" alt="" /> Is not about cancer but is about diseases and evolution so I thought it would be worth mentioning it here. Reading the <a href="http://news.bbc.co.uk/1/hi/health/6959583.stm">BBC</a> I found about this <a href="http://www.who.int/whr/2007/en/index.html">report</a> from the <span class="caps">WHO</span> that says that infectious diseases are emerging at a rate of one per year. The increasing rate of globalisation, with people travelling with increased frequency to all corners of the world means that diseases can spread at a significantly much faster rate.</p>


	<p>The release from the <span class="caps">WHO</span> produced headlines in most of the media around the world (for instance, the <a href="http://www.elpais.com/articulo/opinion/Prevenir/pandemias/elpepuopi/20070826elpepiopi_2/Tes">Spanish press</a>). There was also <a href="http://video.google.com/videoplay?docid=-3453332153097006722&#38;q=charlie+rose+science+series&#38;pr=goog-sl">this TV</a> debate that counted with the presence of Paul Nurse, the Nobel laureate.</p>


	<p>Up to now nothing new but it is reasonable that as human population grows the chances of one of us getting in contact with the wrong virus at the wrong time increase. Also, as we travel more often to more places the chance of transmitting the virus or disease increase significantly.</p>


	<p>So what is the best defence (short of stopping people from travelling)? My guess is that involves having, as accurate as possible, models of diseases spreading if we know where the focus of the disease is and the spreading characteristics of the disease. Another thing is that it probably helps to have populations that are genetically diverse. Since a disease is unlikely to affect everybody in a genetically diverse population, that information could be useful to find out how to better fight the disease.</p>]]>
      </description>
      <pubDate>Wed, 29 Aug 2007 22:18:24 -0000</pubDate>
      <link>http://network.nature.com/blogs/user/basanta/2007/08/29/pandemics</link>
      <guid>http://network.nature.com/blogs/user/basanta/2007/08/29/pandemics</guid>
      <dc:creator>David Basanta</dc:creator>
    </item>
    <item>
      <title>Public debate on complexity and evolution</title>
      <description>
        <![CDATA[<p><img src="http://viking.mech.kcl.ac.uk:51515/~david/me.jpeg" alt="" /> I left Oxford just before the start of the <strong>GECCO</strong> conference in London in early July. <span class="caps">GECCO</span> is the biggest international conference on the subject of artificial evolution and although most of the sessions and talks are about the use of evolutionary algorithms to solve all sorts of problems in engineering, many of the participants are genuinely interested in evolution per se.</p>


	<p><img src="http://www.cs.ucl.ac.uk/staff/p.bentley/panel2.jpg" alt="" /></p>


	<p>One of the milestones of the last <span class="caps">GECCO</span> was the public debate on complexity and evolution organised by <span class="caps">GECCO</span> in one of London&#8217;s most impressive locations, the Natural History Museum. The debate was chaired by <a href="http://www.cs.ucl.ac.uk/staff/P.Bentley/">Peter Bentley</a>, my former PhD advisor and included some of the biggest names in evolutionary biology and development: <strong>Richard Dawkins, Steve Jones</strong> and <strong>Lewis Wolpert</strong>. This debate alone would have been a reason good enough to make <span class="caps">GECCO</span> an event woth attending. For those of us that could not make it, Peter has created this <a href="http://www.cs.ucl.ac.uk/staff/p.bentley/evodebate.html">site</a> in which is possible to download the videocast of the event.</p>]]>
      </description>
      <pubDate>Sun, 26 Aug 2007 21:26:37 -0000</pubDate>
      <link>http://network.nature.com/blogs/user/basanta/2007/08/26/public-debate-on-complexity-and-evolution</link>
      <guid>http://network.nature.com/blogs/user/basanta/2007/08/26/public-debate-on-complexity-and-evolution</guid>
      <dc:creator>David Basanta</dc:creator>
    </item>
    <item>
      <title>View on the health and the income of countries</title>
      <description>
        <![CDATA[<p><img src="http://viking.mech.kcl.ac.uk:51515/~david/me.jpeg" alt="" /> I am trying to relax during my holidays in northwest Spain and for my amusement I read this <a href="http://economist.com/world/international/displaystory.cfm?story_id=9616897">article</a> [Economist].</p>


	<p>They show information from the World Health Organisation that shows that the biggest killer in the world (not just the developed world) are heart diseases. Cancer is responsible for a <em>mere</em> 15.7% of the world deaths.</p>


	<p>This is interesting because, traditionally, heart diseases as a significant health problem, were thought to be the preserve of rich countries but nowadays affects most countries. It seems that as poorer countries improve their living standards (or at least that is what the article claims) more and more people are discovering the diseases that characterise the old age in the developed world. Unfortunately it seems that poor countries are less able to cope with people suffereing from these diseases than richer ones. These diseases also impose a great economic (as well as emotional) burden on the families of the affected.</p>]]>
      </description>
      <pubDate>Mon, 13 Aug 2007 17:30:22 -0000</pubDate>
      <link>http://network.nature.com/blogs/user/basanta/2007/08/13/view-on-the-health-and-the-income-of-countries</link>
      <guid>http://network.nature.com/blogs/user/basanta/2007/08/13/view-on-the-health-and-the-income-of-countries</guid>
      <dc:creator>David Basanta</dc:creator>
    </item>
    <item>
      <title>Stem cells and cancer once again</title>
      <description>
        <![CDATA[<p><img src="http://viking.mech.kcl.ac.uk:51515/~david/me.jpeg" alt="" /> One of the hot topics in cancer research these days is the role of stem cells in cancer initiation. According to one increasingly popular hypothesis, tumour growth is driven by a small subpopulation of stem cells. Stem cells, capable of differentiation and unlimited replication, are indeed a potential source of cancer initiation.</p>


	<p><img src="http://upload.wikimedia.org/wikipedia/commons/thumb/3/3c/Stem_cells_diagram.png/400px-Stem_cells_diagram.png" alt="" /></p>


	<p>Science has published a couple of weeks ago a <a href="http://www.sciencemag.org/cgi/content/full/317/5836/337">study</a> that, according to the authors, shows that (at least in their experiments with xenotransplantation in mice) most cells are capable of seeding a tumour in the new host. About 10% of the transplanted cells could seed a tumour and less than 5% of those were stem cells.</p>


	<p>That is all quite interesting although in my opinion they fail to ask themselves if the cells they xenotransplanted (that are already cancer cells) were or were not initiated by a stem cell.</p>]]>
      </description>
      <pubDate>Thu, 02 Aug 2007 13:51:16 -0000</pubDate>
      <link>http://network.nature.com/blogs/user/basanta/2007/08/02/stem-cells-and-cancer-once-again</link>
      <guid>http://network.nature.com/blogs/user/basanta/2007/08/02/stem-cells-and-cancer-once-again</guid>
      <dc:creator>David Basanta</dc:creator>
    </item>
    <item>
      <title>Profile of Gerd Kempermann,  Center for Regenerative Therapies, Dresden</title>
      <description>
        <![CDATA[<p><img src="http://viking.mech.kcl.ac.uk:51515/~david/me.jpeg" alt="" /> This week&#8217;s edition of Nature comes with the <a href="http://www.nature.com/naturejobs/2007/070726/full/nj7152-508a.html">profile</a> of Gerd Kempermann. He is one of the leaders of the newly opened <a href="http://www.crt-dresden.de/">Center for Regenerative Therapies in Dresden</a> which results from the collaboration of several research groups in Dresden (from the University and the Max Plancks among others) including my own group (as a non core group).</p>


	<p>It seems to be an exciting time to be doing oncological research in Dresden and hopefully there will be opportunities for some collaboration with biologists to test a model I have in mind about the role of stem cells in cancer initiation.</p>]]>
      </description>
      <pubDate>Thu, 26 Jul 2007 11:36:02 -0000</pubDate>
      <link>http://network.nature.com/blogs/user/basanta/2007/07/26/profile-of-gerd-kempermann-center-for-regenerative-therapies-dresden</link>
      <guid>http://network.nature.com/blogs/user/basanta/2007/07/26/profile-of-gerd-kempermann-center-for-regenerative-therapies-dresden</guid>
      <dc:creator>David Basanta</dc:creator>
    </item>
    <item>
      <title>Project on the role of TGF-Beta on prostate cancer</title>
      <description>
        <![CDATA[<p><img src="http://viking.mech.kcl.ac.uk:51515/~david/me.jpeg" alt="" /> The <a href="http://vanderbilt.edu/VICBC">workshop</a> last week at Vanderbilt was very intense and unusual in the sense that, asides from the usual sessions with talks and posters there were group projects in order to get biologists and mathematicians (or other types such as computer scientists, chemists and physicists) to work together.</p>


	<p>The group in which I worked had a fair balance of biologists and mathematicians and, apparently, a keen interest in studying the role of the protein known as <span class="caps">TGF</span>-Beta in prostate tumours. The project focused (and still does, since some of the people in the group will keep working on that) on producing an indivudual-cell based model that could answer questions such as :</p>


	<ul>
	<li>How does the loss of <span class="caps">TGF</span>-Beta responsiveness in epithelial cells (cells in the outer layer of organisms including the colon and the prostate) affect tumour initiation?</li>
		<li>Does the increased production of <span class="caps">TGF</span>-Beta affect tumour progression? and if so, how?</li>
		<li>What is the role of monocytes (immune cells that can be recruited by <span class="caps">TGF</span>-Beta and, when matured, become macrophages) in tumour progression?</li>
		<li>Given that <span class="caps">TGF</span>-Beta produces different and some times, mutually opposed effects in each cell type, is it possible to study this interplay of <span class="caps">TGF</span>-Beta responses in the most relevant cell types?</li>
	</ul>


	<p><img src="http://wwwpub.zih.tu-dresden.de/~basanta/blog/tfgb-outline.png" alt="" /></p>


	<p>The results where pretty spectacular given that we had approximately a couple of days to come with the project, the model, the questions we wanted to approach with the model and some initial simulations. An example of one of these simulations can be seen in movies <a href="http://wwwpub.zih.tu-dresden.de/~basanta/blog/cell.mov">cell</a>, <a href="http://wwwpub.zih.tu-dresden.de/~basanta/blog/bm.mov">bm</a>, <a href="http://wwwpub.zih.tu-dresden.de/~basanta/blog/tgfb.mov">tgf</a> and <a href="http://wwwpub.zih.tu-dresden.de/~basanta/blog/mde.mov">mde</a>. Each of the movies shows a different aspect of the simulations. The <strong>cell</strong> movie shows tumour progression in a domain containing a double layer of basal and lumen cells, separated from the rest by a membrane. In the outside, as shown in the figure there are stromal cells, receptive to <span class="caps">TGF</span>-Beta, and monocytes, that move towards the source of <span class="caps">TGF</span>-Beta once the concentration reaches a certain level. After a few seconds, a mutation transforms one of the epithelial tumour cells into a tumour cell that does not consume <span 